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MODULATION OF HOST POLYUBIQUITINATION BY THE ANKB F-BOX PROTEIN 
OF LEGIONELLA PNEUMOPHILA 
William M Bruckert 
 December 1, 2014 
 Legionella pneumophila is a facultative intracellular pathogen that infects a wide 
array of protozoan hosts and human alveolar macrophages. L. pneumophila is dependent on a 
functional Dot/Icm type IVB secretion system that translocates bacterial effector proteins 
into the host cell cytosol. L. pneumophila genomes encode more than 250 effector proteins, 
many of which inhibit host cellular processes to form a favorable niche termed the 
Legionella-containing vacuole (LCV). The eukaryotic-like Dot/Icm translocated effector 
AnkB contains two eukaryotic-like ankyrin protein-protein interacting domains, one 
eukaryotic-like F- box domain and an eukaryotic C-terminal CaaX motif. Immediately 
following attachment of extracellular bacteria, AnkB is translocated into the host cell where 
it is rapidly farnesylated and anchored to the plasma membrane beneath the attached 
extracellular bacteria. AnkB recruits the host cell SCF1 E3 ubiquitin ligase machinery to the 
point of attachment and promotes the lysine48-linked polyubiquitination of the AnkB 
substrates. Interestingly, the proteasomal degradation of the lysine48-liked polyubiquitinated 
proteins increases the levels of intracellular free amino acids within 15 minutes of attachment 
of extracellular bacteria. This early increase in free cellular amino acids is needed to prevent 
a starvation response and inhibits differentiation into the non-replicative phase which 
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facilitates intracellular replication. The polyubiquitinated proteins surrounding the LCV have 
a wide range of cellular functions, and include the amino acid transporters SLC1A4 and 
SLC3A2 and the sodium bicarbonate transporter SLC4A7. In addition the ubiquitinated 
proteome of the WT strain, the LCV contains proteins involved in the immune response, 
including interferon regulatory factor 7 and Interleukin-1 receptor-associated kinase 1a. The 
complete LCV proteome of the WT strain as well as the ankB mutant strain contained E2 
ubiquitin-conjugation enzymes, E3 ubiquitin ligases and ubiquitin peptidases. Bioinformatic 
analysis determined the major metabolic networks within the LCV proteome, including the 
phosphatidylinositol 4,5 diphosphate pathway and multiple amino acid synthesis pathways. 
These data showed that AnkB is polyubiquitinated on lysine 67 through lysine11-linked 
polyubiquitination. While lysine11-linked polyubiquitination has been shown to target the 
modified protein for proteasomal degradation, stability of AnkB is not affected following 
ubiquitination. This highlights a novel example of an F-box effector protein that is modified 
though lysine11-linked polyubiquitination. Taken together, AnkB manipulates multiple 
eukaryotic cellular pathways to enable intra-vacuolar proliferation of L. pneumophila.    
vii 
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I. Etiology and historical aspects of Legionnaires’ disease 
Legionnaires’ disease was first described in 1976 following an outbreak of 
pneumonia at the American Legion Convention in Philadelphia, Pennsylvania, which 
included 34 death [1, 2]. The causative agent was determined to be a facultative intracellular 
Gram-negative bacterium, assigned the name Legionella pneumophila and the strain was 
designated Philadelphia-1 [1]. L. pneumophila belongs to the Legionellaceae family in the 
gamme-2 subdivision of the Proteobacteria, in which the Legionellales order has been 
created [3-5]. The Legionellales order contains two families: Legionellaceae and 
Coxiellaceae, each having the characteristics of being intracellular parasites infecting 
humans, animals and protozoa [6]. Within the Legionellaceae family there are ~60 species 
and 72 serogroups of bacteria which have been isolated from clinical and environmental 
conditions [7, 8]. L. pneumophila consists of 16 serogroups, of which serogroup 1 is the most 
common in infection, followed by 4 and 6 [9, 10]. In the United States L. pneumophila 
represents more than 90% of community or hospital acquired Legionnaires’ disease cases, 
with serogroup 1 responsible for approximately 70% [10]. However, in Western Australia 
and New Zealand L. longbeachae accounts for 30.4% of community acquired Legionnaires’ 
disease cases [11, 12].
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II. Epidemiology and clinical manifestations of legionellosis 
      L. pneumophila is capable of causing Legionnaires’ disease and Pontiac fever, both 
known as legionellosis. Humans acquire legionellosis through the inhalation of 
L.pneumophila containing aerosols, primarily from mechanical means such as showers, water 
fountains, spas and  air conditioning towers [13-15]. Following an incubation period of 2-10 
days the initial clinical symptoms of Legionnaires’ disease, often nonspecific, include mild 
cold symptoms, malaise, low fever, headache, anorexia and muscle aches [8, 16, 17]. 
Without treatment, symptoms progress to a high fever accompanied by a life threatening 
pneumonia, fibrinolysis, cellular infiltrations of macrophages and neutrophils, and alveolar 
damage [8, 18, 19]. Pontiac fever is an acute, self-limiting, non fatal respiratory infection 
without pneumonia [20]. The symptoms of Pontiac Fever, which mimic influenza infection, 
are fever, chills, sore throat, abdominal pain and a nonproductive cough [20-22]. The 
immune system of the host is critical for L. pneumophila  infection, as healthy individuals 
typically clear the infection, individuals with chronic lung diseases, diabetes or chronic renal 
failure have a high risk of disease development if infected [10, 23]. Annually there are an 
estimated 25,000 worldwide cases of pneumonia caused by  L. pneumophila, with 
approximately 10,000 cases in the USA according to the Center of Disease Control and 
Prevention, with a mortality rate ranging from 7-24% [24]. However, it is assumed that only 
2-10% of Legionnaires disease cases are reported [25]. Nosocomial L. pneumophila 
infections have a fatality rate  reaching 50% and are associated with recent surgeries, 
mechanical ventilation, and transplant procedures such as heart and liver [26-28]. 
Legionnaires’ disease is always transmitted from the environment to humans; therefore, 
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environmental monitoring of cooling towers and related water sources should be routinely 
surveyed to control the spread of the disease.  
 
III. Ecology of L. pneumophila within the aquatic environment. 
      L. pneumophila is ubiquitous in natural water sources such as rivers and lakes, as well 
as manmade water systems such as air conditioning units, water fountains and  cooling 
towers [13, 14, 29, 30]. L. pneumophila and other bacterial species form biofilms in the 
aquatic environment, which have been shown to increase their resistance to microbial 
disinfection techniques such as chlorination and UV treatment [31, 32]. Within aquatic 
environments L. pneumophila invade and replicate within many species of protozoa, which 
play a pivotal role in the amplification of the organism as well as providing an intracellular 
habitat capable of providing adequate nutrients and protecting the bacteria from high 
temperature, drying, and chlorination of the extracellular environment [33, 34].                     
L. penumophila grown in amoeba have a greatly increased resistance to the antimicrobial 
properties of the biocides polyhexamethylene biguanide (PHMB) and benzisothiazolone 
(BIT), and are 1,000 fold more resistant to the antimicrobial effects of rifampin and 
ciproflaxin [35, 36]. Furthermore, L. pneumophila grown in amoeba are 100 and 10 fold 
more invasive for epithelial cells and macrophages, respectively [37]. This increase in 
infectivity is associated with changes in bacterial morphology, cell wall composition and 





IV. Transmission and entry of L. pneumophila to amoeba and macrophages        
Inhalation of aerosolized water droplets containing infectious L. pneumophila can 
occur through multiple routes following the bacteria-protozoan interaction. Following escape 
from the protozoan host or biofilm, infectious extracellular L. pneumophila can be 
transmitted to humans through a contaminated water source. Other possible routes of 
infection include the inhalation of excreted L. pneumophila-filled vesicles or amoeba filled 
with L. pneumophila [40, 41]. L. pneumophila uptake into macrophages is mediated by 
human monocyte complement receptors CR1 and CR3 which trigger microfilament-
dependent phagocytosis, while L. pneumophila uptake by amoeba is microfilament-
independent [42-44]. L. pneumophila attachment to the protozoan host Hartmannella 
vermiformis is associated with a 170-kD galactose/N-acetyl-D-galactosamine (Gal/ GalNAc) 
inhibitable lectin and subsequent tyrosine dephosphorylation of multiple host cytoskeletal 
proteins [45-47]. However, in Acanthamoeba polyphaga bacterial attachment is not 
associated with the galactose/N-acetyl-D-galactosamine (Gal/ GalNAc) inhibitable lectin, and 
there is only a slight tyrosine dephosphorylation of a single host protein [45]. Uptake into H. 
vermiformis occurs mainly through cup-shaped invaginations (zipper phagocytosis), while 
coiling phagocytosis is used by Acanthamoeba castellanii and human macrophages [37, 47-
49]. Thus, L. pneumophila has evolved diverse mechanisms to invade different species of 






V. L. pneumophila intracellular life cycle  
In contrast to the diverse mechanisms of attachment and uptake of L. pneumophila by 
protozoa and human cells, intracellular trafficking and survival techniques of the bacterium 
are indistinguishable between the two evolutionary distant hosts [50-52]. Upon inhalation of 
infectious L. pneumophila water droplets, human alveolar macrophages use coiling 
phagocytosis to ingest the bacterium [53, 54]. Following entry, L. pneumophila intercepts 
ER-to-Golgi vesicular traffic and resides in a membrane-bound vacuole (Legionella-
containing vacuole) that becomes surrounded with endoplasmic reticulum derived smooth 
vesicles, mitochondria and other host cell organelles within five minutes [51, 55, 56]. Within 
4 hours following infection the smooth vesicles on the Legionella containing vacuole (LCV) 
are replaced with a ribosome studded multilayer membrane derived from the rough 
endoplasmic reticulum [48, 52, 57]. Importantly, wild type L. pneumophila evades 
phagosome-lysosome fusion in human macrophages or amoeba as seen by the absence of the 
lysosomal markers LAMP-1, LAMP-2 and cathepsin D on the LCV [48, 58-60]. L. 
pneumophila begins multiplying after a four hour log phase, and continues until the LCV 
membrane ruptures, releasing bacteria into the cytosol where two-three rounds of additional 
replication occur [13, 61]. Eventually the lack of nutrients causes a starvation response and 
differentiation into the post exponential phase, resulting in the bacteria lysing the 
macrophage and release of bacteria into the extracellular environment to infect a new host 
[51, 52]. During infection of macrophages, L. pneumophila causes activation of caspase-3 
throughout the infection, however, apoptotic cell death is not initiated until late stages of the 
infection [62-66]. L. pneumophila prevents premature caspase-3 induced apoptotic cell death 
by triggering anti-apoptotic signaling through NF-kappaB activation and inhibition of the 
6 
type I interferon response [67-69].  L. pneumophila has been shown to kill human 
macrophages and A. polyphaga through temporal induction of necrosis, mediated by the 
pore-forming toxin activity of L. pneumophila upon termination of intracellular replication 
[61, 70, 71]. Mutants defective in pore-forming toxin activity replicate to the same extent as 
the wild type strain, however, they fail to lyse the host cell and remain trapped within the 
LCV [61, 72]. Therefore, intracellular replication and phagosomal remodeling through 
interception of host cell vesicular trafficking is independent of host cell lysis. 
 
VI. Characterization of the LCV proteome 
 Using the JR32 Philadelphia-derived strain of L. pneumophila the LCV proteome has 
been profiled from RAW264.7 mouse macrophages [73, 74]. The LCV proteome has also 
been generated using the Corby strain of L. pneumophila in the amoeba host Dictyostelium 
discoideum [73-75]. While the LCV proteome from RAW264.7 macrophages presents 
information on LCV biogenesis, RAW264.7 macrophages originate from the BALB/C 
mouse, whose primary macrophages are non-permissive to L. pneumophila infection [76, 
77]. The LCV proteome analysis from Dictyostelium discoideum contained 566 host proteins 
[73], while the LCV proteome from RAW264.7 macrophages contained 1156 proteins [74]. 
A large proportion (>50%) of the identified proteins were associated with cellular 
metabolism, while proteins involved in signaling and trafficking were found in lower 
abundance (~10% each) [74].  The LCV recruits small GTPases, such as Rab1, Sar1 and 
ADP ribosylation factor 1, which are critical for ER-to-Golgi trafficking [56, 78, 79]. In 
addition, 14 other Rab GTPases were identified in the proteome which include Rab2, Rab4, 
Rab5, Rab7, Rab8 [74]. These Rab GTPases indicate the fusion of the LCV with early and 
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late endosomes and distinct vesicle trafficking pathways in the host cell. The LCV is 
decorated with phospatidylinositol-4 phosphate (PI(4)P), which multiple Dot/Icm bacterial 
secreted effector proteins (SidC, SidM, SdcA, Rid) bind on the LCV membrane [80-82]. 
While there were 60 Dot/Icm effector proteins identified in the RAW264.7 LCV proteome 
analysis, some of these effectors have transmembrane domains which could allow them to 
localize to the LCV (MavP, MavE), it is unknown how the other effector proteins anchor into 
the LCV [74, 83]. Post-translational modifications, such as farnesylation or ubiquitination, of 
effector proteins could alter their sub-cellular localization and allow the effectors to localize 
with the LCV, or with vesicles that fuse with the LCV during vacuole biogenesis. The 
effectors on the LCV could interact with specific host proteins critical for intracellular 
survival.  
 
VII. L. pneumophila metabolism 
L. pneumophila obtains carbon and energy from amino acids, primarily through the TCA 
cycle, with Ser, Glu, Tyr and Thr used for growth in vitro, and Cys, Gln, Ser, and Arg 
supporting growth in vivo [84, 85]. L. pneumophila is auxotrophic for 7 amino acids (Cys, 
Met, Arg, Thr, Val, Ile and Leu), and expresses ~12 classes of ATP-binding cassette 
transporters [86] and amino acid permeases encoded in the genome [87, 88]. Intracellular 
replication of L. pneumophila is dependent upon the host cell amino acid transporter 
SLC1A5 during intracellular infection of human macrophages [85, 89].With L. pneumophila 
having a doubling time of ~40 minutes in macrophages and amoeba, acquisition of host 
amino acids is critical to provide the essential nutrients to support the energy spent during 
intracellular survival and proliferation [90]. It has been shown that L. pneumophila 
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incorporates host cell amino acids during infection of Acanthamoeba castelannii,[91]. 
Therefore it is likely that host amino acid transporters are localized to the LCV; however, this 
has not been evaluated. While amino acids are the major source of carbon and energy, L. 
pneumophila can convert exogenous glucose to pyruvate through the Entner-Doudoroff 
pathway [88, 92]. The Entner-Doudoroff pathway plays an important role in the infection 
process since Entner-Doudoroff pathway mutants have a significant growth defect in 
Acanthamoeba culbertstoni, A/J mouse macrophages and A549 human epithelial cells [92]. 
Interestingly, the ankB mutant which is defective for intracellular replication due to a lack of 
amino acids, can be rescued for growth with the addition of pyruvate to the growth medium 
[86]. Therefore, intracellular replication of L. pneumophila is dependent upon more than 
amino acids, and is a combination of other carbon and energy sources, although amino acids 
are the major source of carbon and energy.  
 
VIII. L. pneumophila biphasic life cycle 
In natural environments, L. pneumophila alternates between a replicative phase and a 
highly infectious nonreplicative transmissive phase [34, 93]. As vacuole nutrients become 
limiting during late stages of intra-vacuolar proliferation, exponential phase bacteria respond 
by producing the alarmone ppGpp, which stimulates signaling pathways responsible for the 
differentiation and phenotypic phase variation seen upon entering the post-phase [94, 95]. 
The ppGpp synthases RelA and SpoT are essential for phenotypic variation and become 
activated during nutrient limitation at the end of intracellular replication, which causes an 
increase in the alarmone ppGpp [94-96]. In response to the increase of ppGpp the sigma 
factor RpoS and the LetA/S two component system coordinate the activation of many 
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transmission virulence traits (cytotoxicity, flagellum synthesis, increased osmotic resistance, 
increased resistance to extracellular stresses, and evasion of the endocytic pathway). These 
transmission virulence traits are not expressed by exponential replicating bacteria, and are 
thought to be required for escaping a nutrient-deprived host, gaining entry into the next host, 
and suppressing traits dedicated to intracellular replication [94-96]. The repressor of 
transmission traits, CsrA, is active exclusively during the replicative phase while lysosomal 
evasion traits are inactive during intracellular replication [60, 97]. The flagella sigma factor 
FliA, which activates several genes needed for flagellum development, is required for the 
post-exponential traits of motility, cytotoxicity,  infectivity and lysosome evasion [98, 99]. 
Genes regulated by FliA could explain how L. pneumophila can exit one host and block 
phagolysosomal fusion in the next.  
 
IX. L. pneumophila type II and 1V secretion systems 
Gram-negative bacteria have developed sophisticated secretion systems in order  
to deliver effector molecules from the bacteria cell to the cytoplasm of the  host cell or to the 
extracellular environment. Of the eight well characterized secretion systems in Gram-
negative bacteria, L. pneumophila contains a functional type II (Lsp) and type IV (Dot/Icm) 
secretion system [100-103]. The L. pneumophila type II  secretion system involves the Sec or 
Tat pathway, which secretes proteins across the bacterial inner membrane to the periplasm, 
where proteins are unfolded and secreted across the outer bacterial membrane through the 
type II secretion system complex [104, 105]. The L. pneumophila type II secretion system is 
responsible for the secretion of many degradative enzymes such as acid phosphatases, 
lipases, aminopeptidases, and a zinc metalloprotease [106-109]. L. pneumophila type II 
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secretion is required for the intracellular infection of Acanthamoebae and Hartmannellae, 
optimal intracellular infection of human macrophages, and virulence in the murine model 
[100, 110, 111]. 
The Dot/Icm Type IVB secretion system was coincidentally discovered by 2 groups 
who sought to determine L. pneumophila virulence traits by generating spontaneous mutants 
and assessing their ability to replicate within macrophages, and to avoid phagosome-
lysosome fusion [112, 113]. The L. pneumophila spontaneous avirulent strain 25D was 
restored for intracellular replication when a region of the chromosome (intracellular 
multiplication (Icm)) was complemented with the wild type strain region of the chromosome 
[113-115]. Subsequently, a second region of the genome (defect in organelle trafficking 
(Dot)) was able to restore phagosome-lysosome evasion and association with host cell 
organelles in an avirulent strain [112, 116]. The Dot/Icm loci are composed of 26 genes 
responsible for the assembly of a sophisticated type IVB secretion system [103, 117, 118]. 
Type IV secretion systems (T4SS) are macromolecular systems with homology to the 
conjugation machinery required for the conjugation of plasmids between bacteria [103, 119, 
120]. The Dot/Icm secretion system is made up of 22 structural proteins, many of which are 
membrane associated, and 5 chaperone proteins that interact with effector proteins in the 
bacteria cytoplasm [121, 122]. In contrast to the Lsp Type II secretion system which secretes 
approximately 20 proteins, primarily degradation enzymes to the extracellular environment, 
the Dot/Icm secretion system translocates more than 250 bacterial proteins directly into the 
host cell cytoplasm [123]. L. pneumophila is naturally competent in the environment, 
therefore the ability to transfer the Dot/Icm effector proteins from one bacterium to another 
could account for this extraordinary number of effectors compared to other bacteria [124]. 
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Despite the requirement for a functional type IV secretion system for intracellular replication 
and phagosome-lysosome evasion, loss of single effectors rarely cause a significant growth 
defect [125, 126]. This is thought to primarily result from redundancy among the effector 
proteins, however single deletion mutants of many effectors have not been analyzed [125].  
 
X. L. pneumophila Dot/Icm substrate identification and functions 
The requirement of the Dot/Icm secretion system for intracellular infection has lead 
research into the identification and characterization of the translocated substrates. Techniques 
utilized to identify L. pneumophila translocated effectors include genetic assays in yeast, 
proteins interacting with Dot/Icm components, bioinformatic searches for genes encoding 
eukaryotic domains, and direct translocation assays looking for the presence of the effector 
protein within host cells [123, 127-130]. In addition, L. pneumophila effector proteins were 
identified by using the T4SS chaperone-like IcmW protein as bait in a yeast two-hybrid 
screen [127]. Translocation has been determined using fusion reporters such as the adenylate 
cyclase and beta-lactamase assays, where the bacterial gene of interest is fused to the 
Bordetella pertussis adenylate cyclase catalytic domain, or the carboxyl end of TEM-1 beta-
lactamase, respectively [123, 131, 132]. The calmodulin-dependent adenylate cyclase assay 
causes a dramatic increase in intracellular cyclicAMP levels when the fusion protein is 
translocated into host cells [133]. In the fluorescent resosnance energy transfer (FRET) assay 
based on TEM-1 β-lactamase activity, the host cells are loaded with a β-lactamase substrate 
(CCF4-AM), which emits green fluorescence (520nm). If the effector protein containing the 
TEM-1 fusion reporter is translocated into loaded cells, the substrate will be cleaved and emit 
blue fluorescence (447nm), allowing translocation to be determined by measuring the ratio of 
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cleaved to uncleaved substrate in infected cells. Antibodies specific for Dot/Icm substrate 
proteins have been utilized in confocal microscopy to determine sub-cellular localization in 
the host cell [124, 134-136].  
Sequence analysis of L. pneumophila genomes identified many of the predicted and 
experimentally verified Dot/Icm substrates are similar to eukaryotic proteins or have motifs 
commonly found in eukaryotic proteins [137, 138]. These effectors are thought to have been 
acquired through horizontal gene transfer during the evolution of L. pneumophila with 
primitive eukaryotic host cells such as amoeba [137, 138]. L. pneumophila encodes effectors 
with eukaryotic like motifs such as Set domains, ankyrin domains, U-box and F-box motifs, 
and eukaryotic like proteins such as sphingosine kinase and phosphatases [139, 140]. Many 
of the eukaryotic like proteins interfere with host cell pathways contributing to intracellular 
trafficking, and manipulation of host cell processes that are advantageous to intracellular 
bacterial survival [141, 142].  
Despite the requirement for a functional type IV secretion system for intracellular 
replication and phagosome-lysosome evasion, loss of a single effector rarely causes a 
significant defect in intracellular replication [125, 126]. The effector protein DrrA (SidM) is 
necessary for host cell Rab1 recruitment to the LCV, while the effector protein LidA 
enhances this Rab1 recruitment, showing a specific redundancy in the functions of different 
effector proteins [143-145]. The host guanosine triphosphatase (GTPase) Rab1 is recruited to 
the LCV within 5 minutes of uptake, and is involved in the recruitment of ER-derived 
vesicles to the LCV to create a replicative niche [78, 146, 147]. A lidA mutant of  L. 
pneumophila strain has a slight growth defect in human macrophages, while intracellular 
replication of a DrrA (sidM) mutant strain was similar to wild-type L. pneumophila [134, 
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143]. The L. pneumophila effector protein SdhA has been shown to be involved in 
maintaining the integrity of the LCV and preventing host cell death through suppression of 
type 1 interferon, while the effector SidF also inhibits host cell death by inhibiting pro-
apoptotic signaling through Bcl2 [69, 148, 149]. Interestingly, a L. pneumophila  sdhA 
mutant strain was severely impaired for intracellular growth within A/J mouse macrophages 
due to caspase-1 dependent host cell death [150, 151]. However, in U937 macrophages and 
D. discoideum intracellular replication was only partially impaired in the sdhA mutant strain 
[150]. In contrast to the effectors causing anti-apoptotic signaling at least five effectors of  L. 
pneumophila are capable of causing caspase 3 activation [152]. Inhibiting host protein  
translation is one of the main mechanisms of L. pneumophila effectors [153, 154].  At least 5 
effectors (Lgt1, Lgt2, Lgt3, SidI, SidL) inhibit host protein translation by modifying the host 
elongation factor eEF1A or by binding the host elongation factor EF1Bγ, which blocks 
protein translation [153, 155].  Importantly, the effectors that block translation lead to an 
exasperated Map kinase response where host transcribed mRNA fail to be translated [155]. 
During L. pneumophila induced translation inhibition, selected genes such as IL-1α and IL-
1β are still translated, which is likely due to them being the most abundant transcripts during 
L. pneumophila infection [155, 156].  These examples highlight the ability of L. pneumophila 
to manipulate a wide variety of host cellular pathways to obtain a favorable intracellular 
environment during infection.  
 
XI. L. pneumophila eukaryotic-like ankyrin proteins 
Through bioinformatic analysis of L. pneumophila genomes, many eukaryotic-like 
proteins have been identified, which are thought to have been acquired through horizontal 
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gene transfer [129, 137, 138, 142]. Eukaryotic proteins containing ankyrin domains are 
broadly distributed in the cytoplasm and the nucleus and act as adaptors to mediate specific 
protein-protein interactions [157, 158]. The 33 amino acid ankyrin repeat (ANK) is the most 
prevalent motif found in protein databases [159-163]. Eukaryotes contain the majority of 
ankyrin repeat proteins, while bacteria, archaea and viruses have ankyrin repeat proteins as 
well [159]. Eukaryotic ankyrin proteins are involved in development, cell signaling, 
inflammatory response, inhibition or development of tumors, cell-cycle regulation and signal 
transduction [164-166]. The ankyrin motif exhibits helix-turn-helix conformation, with the 
beta loop projected outward to bind the target protein [167-169]. The ANK repeat binding 
site consists of six non-conserved amino acid residues, which determine the specific target of 
the ankyrin protein [170, 171]. Ankyrin proteins have been identified in many different 
bacterial pathogens such as Wolbachia, Pseudomonas, Coxiella, Anaplasma and Legionella 
[129, 172-175]. Coxiella burnetti translocated ankyrin proteins localize to different host cell 
organelles, where they are hypothesized to manipulate host cell processes such as apoptosis 
and vesicular fusion events critical for infection [174].  
L. pneumophila strains Corby, Lens, Paris and Philadelphia contain at least eleven 
common ankyrin genes (ankB, ankC, ankD, ankE, ankF, ankG, ankH, ankI, ankJ, ankK, 
ankN), which exhibit extensive size and sequence variation [129, 159].The ankyrin proteins 
in L. pneumophila vary extensively, such as containing between 1-11 ANK repeats, one F-
box domain, and one SET motif [129]. Adenylate cyclase translocation assays revealed at 
least eight of the ankyrin proteins are translocated into the host cell through the Dot/Icm 
T4SS [176]. Most of the ankyrin genes are upregulated in vitro and within A. polyphaga 
during the transition to the post-exponential phase in an RpoS-dependent mechanism [129, 
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177]. While eight of the ankyrin genes are dispensable for intracellular growth, AnkH, AnkJ, 
and AnkB play crucial roles in the infection of hMDMs and multiple protozoan hosts [129, 
131]. The L. pneumophila ankH and ankJ mutant strains exhibit a major defect in 
intracellular replication within human macrophages, a partial defect within A. polyphaga and 
H.vermiformis, and are attenuated in the mouse model of Legionnaires’ disease [129, 176]. 
The ankyrin domains and the last ten C-terminal amino acid residues of AnkH and AnkJ are 
required for translocation and proficient intracellular replication [176]. The ankH and ankJ 
mutant strains exhibited similar intracellular trafficking as the wild-type strain, indicating 
these effector proteins are not involved in vacuole formation or trafficking, but are needed to 
promote intracellular replication within the LCV [176].  
 
XII. L. pneumophila manipulation of host prenylation machinery 
Prenylation is an irreversible post-translational lipid modification of a protein, involving 
the covalent addition of a 20-carbon geranygeranyl group or a 15-carbon farnesyl isoprenoid 
group, to a cysteine residue within the conserved C-terminal CaaX motif (in which “a” is any 
aliphatic amino acid and “X” is any amino acid)  [178, 179]. This modification increases 
protein hydrophobicity, which results in anchoring of the protein to the lipid bilayer of cell 
membranes or organelle membranes [180, 181]. In humans three different protein 
prenyltransferases facilitate protein prenylation: two geranylgeranyl protein transferases 
(GGtase I and II) and one farnesyltransferase (FTase) [182, 183]. Following prenylation of 
the cysteine, the terminal “aaX” tripeptide is cleaved by RAS-converting enzyme 1 (RCE-1), 
and the prenylcysteine is carboxymethylated by isoprenyl cysteine carboxyl methyl 
transferase (ICMT) [184, 185].  Labeling experiments have estimated that ~2% of the 
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mammalian proteome is prenylated, and the characterized farnesylated or geranylgeranylated 
proteins include kinases, phosphatases, GTP-binding proteins and nuclear lamins [186, 187]. 
The most characterized CaaX motif proteins are Ras GTPases and trimeric G proteins, which 
require an additional signal to target specific cellular compartments [188, 189]. The signal in 
Ras proteins is located immediately upstream from the CaaX motif known as the 
hypervariable domain, while trimeric G proteins must become modified through the 
attachment of the fatty acid palmitate or myristate on the α subunit [190, 191]. CaaX motif-
containing proteins are involved in cellular signaling processes and regulatory events 
including cell proliferation, differentiation, metabolism, apoptosis and nuclear stability [192-
194].  
Genomic analyses of 17 intracellular and extracellular pathogens predicted 54 
proteins from 14 species, including Salmonella, Legionella, Yersinia, Francisella among 
others, have the C-terminal CaaX motif that could be subjected to host prenylation [195, 
196]. The Salmonella enterica T3SS effector protein SifA is geranylgeranylated, resulting in 
localization to the Salmonella containing vacuole (SCV) and Salmonella-induced filaments, 
where it interacts with host cell Rab7, and plays a role in preventing Salmonella-containing 
vacuole-lysosome fusion [197, 198]. In the L. pneumophila strains Philadelphia, Lens, 
Corby, and Paris eleven CaaX motif-containing proteins (CMPs) were identified, with six of 
the proteins being conserved among the sequenced L. pneumophila strains [199, 200]. The 
adenylate cyclase translocation assay identified seven of the Legionella CMPs are 
translocated into the host cell through the Dot/Icm T4SS [199, 200]. Legionella CMPs are 
substrates of eukaryotic prenylatransferases, causing lipidation and enabling their targeting to 
specific cellular membranes [199]. When ectopically expressed in human cells, Legionella 
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CMPs localize as intense punctuate spots or around the cell periphery, indicating vesicular or 
plasma membrane localization, respectively [199]. Inhibition of prenylatransferases cause a 
significant but modest increase in wild-type LCV’s acquiring the lysosomal markers LAMP1 
and Cathepsin D [199]. Therefore, manipulation of host cell prenylation machinery through 
L. pneumophila CMPs contributes to evasion of phagosome-lysosome fusion and enhances 
the ability of remodeling of the LCV.   
  
XIII. Bacterial manipulation of host ubiquitination machinery 
 Posttranslational modifications of proteins are conserved mechanisms for regulating 
protein activity, localization, conformation, or stability. Protein modifications, usually driven 
by enzymes, include phosphorylation, lipidation, protonation, ubiquitination, and prenylation. 
Many pathogenic bacteria use translocated effectors to manipulate host cell posttranslational 
machineries to promote intracellular bacterial replication and survival.  
 Ubiquitination is a conserved eukaryotic post-translational protein modification 
involving the addition of a 76 amino acid ubiquitin moiety onto a substrate protein via 
isopeptide bond between free carboxy group on the terminal glycine of ubiquitin and the ɛ 
amino on lysine of the target protein [201, 202]. Polyubiquitination is the covalent linkage of 
ubiquitin monomers through 1 of 7 lysine residues in ubiquitin (K6, K11, K27, K29, K33, 
K48, K63) [202, 203]. The fate of the polyubiquitinated protein depends on the lysine residue 
within ubiquitin that is involved in the ubiquitin-ubiquitin chain linkage [203, 204]. 
Polyubiquitination through K63 regulates nonproteolytic cellular processes, such as 
`transcriptional activation, protein localization, innate immune response, cell cycle 
progression and DNA damage response [205-208]. If ubiquitin monomers are linked through 
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K48 residues, the substrate protein is recognized by the 26S proteasome and degraded [209, 
210]. While polyubiquitination through K6, K11, K27, K29 and K33 is less studied, however 
with new techniques it is becoming more common to observe these types of 
polyubiquitination, it has been shown these linkage patterns can cause substrate degradation, 
endocytosis, signaling and regulation [211-213]. Polyubiquitination occurs through a three-
step process involving activation of ubiquitin by an E1 enzyme [214], allowing for transfer of 
the ubiquitin moiety to a ubiquitin-conjugating enzyme (E2) [215], followed by transfer onto 
the targeted protein via substrate specific ubiquitin-protein ligases (E3) [216]. There are 
>1,000 estimated substrate-specific ubiquitin ligases, classified into two major groups, 
RING-type and HECT-type [216, 217]. The SKP1-CUL1-F-box (SCF) complex is a well 
characterized RING-type E3 ubiquitin ligase complex [218]. The E2 ubiquitin conjugating 
enzyme binds the RBX1 RING finger protein, which associates with the C terminus of the 
cullin (CUL1) [215]. The F-box domain of the F-box protein binds directly to SKP1, which 
links the F-box protein to CUL1 to cause ubiquitination of the substrate protein that is bound 
to another domain of the F-box protein [219, 220]. F-box containing proteins generally have 
a recognizable substrate protein binding domain, such as a WD40 or a leucine rich repeat, 
which bind specific substrates to be ubiquitinated [221, 222].  
Bioinformatic analyses have revealed eukaryotic-like F-box proteins in human 
pathogens, plant pathogens, viruses, and amoebal endosymbionts [223-225]. The plant 
pathogen Agrobacterium encodes 694 potential F-box proteins, while there have been ~70 F-
box proteins identified in humans [226, 227]. L. pneumophila encodes five F-box proteins 
(AnkB, LegU1, LicA, Lpg2224, Lpg2525) that are translocated into host cells through the 
Dot/Icm T4SS [228]. LegU1 and AnkB associate with the SKP1 and CUL1 components of 
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the SCF E3 ubiquitin ligase complex, while LicA only interacts with SKP1 [228]. LegU1 
specifically interacts with and causes ubiquitination of the host cell chaperone protein BAT3 
[228]. In BAT3 knockout mammalian cells there is an increased resistant to ER stress, 
therefore, multiple L. pneumophila F-box proteins could target BAT3 for proteasomal 
degradation to modulate the host ER stress response [228] The L. pneumophila Dot/Icm 
translocated effector LubX contains 2 domains very similar to the U-box, a domain found in 
eukaryotic E3 ubiquitin ligases [229]. LubX functions as an E3 ubiquitin ligase, causing 
polyubiquitination and proteasomal degradation of the L. pneumophila effector protein SidH 
[230]. A number of bacterial pathogens such as Yersinia, Salmonella and Pseudomonas have 
effector proteins that manipulate eukaryotic ubiquitination machinery [231]. The Salmonella 
effector SopA is ubiquitinated in a proteasomal dependent manner [232, 233], while SopB is 
ubiquitinated through K63-linked polyubiquitination which alters its subcellular localization 
[234]. The Pseudomonas aeruginosa effector ExoU could be modified through a diubiquitin 
chain following translocation [235, 236]. To date no bacterial effector protein has been found 
to be modified through K6, K11, K27, K29 or K33-linked polyubiquitination. Interestingly, 
intracellular replication by L. pneumophila is dependent upon K48-linked polyubiquitination 
of the LCV in a proteasome-dependent mechanism [237, 238]. Therefore, L. pneumophila 
utilizes acquired eukaryotic-like F-box proteins to manipulate the host cell ubiquitination 






XIV. L. pneumophila T4SS effector AnkB 
 
 
Figure 1. A model of the domain structure of AnkB. AnkB is a eukaryotic-like F-box 
protein that contains 2 ankyrin domains. The C-terminus of AnkB contains a 
eukaryotic CaaX motif (CLVC).  
 
The L. pneumophila ankB gene, conserved among all sequenced strains, encodes a 
172 amino acid protein that contains two eukaryotic-like ankyrin domains and a conserved N 
terminus eukaryotic-like F-box domain [129, 131]. In the Paris strain and the AA100/130b 
strain of L. pneumophila, a mutation in ankB causes a severe defect in intracellular 
replication in human macrophage and A. polyphaga [131, 238, 239]. However, in the 
Philadelphia-derived Lp02 strain, a mutation in ankB does not result in a growth defect 
within human macrophages or amoeba [228]. In the AA100/130b strain, in-frame deletions 
of single ankyrin domains in the ankB gene result in a partial defect in intracellular 
replication, while a deletion in both ankyrin domains abolishes intracellular replication 
identical to the ankB null mutant [240]. Upon extracellular bacterial attachment, AnkB is 
translocated and triggers assembly of polyubiquitinated proteins directly beneath bacterial 
attachment site [238]. The C-terminal CaaX motif of AnkB is prenylated though the addition 
of a farnesyl group, enabling AnkB to anchor into the plasma membrane beneath bacterial 
attachment and subsequently to the cytosolic face of the LCV membrane [135]. Through 
conserved residues in the F-box domain, AnkB directly interacts with the SKP1 component 
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of the SCF1 E3 ubiquitin ligase complex to recruit K 48 -linked polyubiquitinated proteins to 
the LCV [241]. The K 48 -linked polyubiquitinated proteins are degraded by the proteasomes 
to generate a surplus of free cellular amino acids that are utilized by the bacterium to provide 
the carbon and energy for intracellular replication [86]. When macrophages are supplemented 
with an amino acid mixture, the ankB mutant strain is rescued for intracellular growth, 
suggesting that the function of AnkB is to provide amino acids as nutrients for intra-vacuolar 
bacteria [86]. Therefore, AnkB exploits eukaryotic cellular processes to trigger K48 -linked 
polyubiquitination on the LCV. The polyubiquitinated substrates are degraded by the 26S 
proteasome to generate free cellular amino acids that are imported into the LCV for use as a 




AnkB is the only ankyrin effector to be translocated from the site of extracellular 
bacterial attachment [129] and it has been shown that polyubiquitinated proteins appear 
within 15 minutes of bacterial attachment. Therefore, it is likely that AnkB is farnesylated 
immediately following bacterial attachment, and interacts with the SCF1 E3 ubiquitin ligase 
complex to cause polyubiquitination of its substrates. The proteasomal degradation of the 
polyubiquitinated substrates will generate an increase in free cellular amino acids to inhibit 
differentiation into the non-replicative phase and power intracellular replication.                    
L. pneumophila is auxotrophic for seven amino acids, therefore acquisition of host cell amino 
acids is critical for intracellular survival and replication. Further characterization of the 
ubiquitinated proteins localized to the LCV will provide potential substrates of AnkB that 
can be further investigated to determine their role during L. pneumophila infection.  
 
I hypothesize, that once L. pneumophila makes contact with the host cell, AnkB is 
rapidly translocated and farnesylated which allows it to integrate into the LCV membrane 






To test this hypothesis my specific aims are: 
Specific Aim 1: Study the kinetics of AnkB translocation upon attachment of extracellular    
L. pneumophila, and determine if the host cell farnesylation and ubiquitination machineries 
are localized and manipulated at the site of extracellular bacterial attachment. 
Specific Aim 2: Characterize the complete and ubiquitinated proteome of the Legionella-
containing vacuole from human macrophages.  
Specific Aim 3: Determine if AnkB is ubiquitinated and the type of polyubiquitin chain 
linkage.
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MATERIALS AND METHODS 
 
Bacterial strains, cell cultures  
L. pneumophila strain AA100/130b (ATCC BAA-74), the isogenic ankB and dotA 
mutants were grown on buffered charcoal yeast extract (BCYE) agar plates for 3 days at 
37°C prior to use in infections as described previously [131]. Escherichia coli strain 
DH5α was used for cloning and plasmid preparation purposes. Human monocyte-derived 
macrophages (hMDMs) and U937 cells were cultured using RPMI1640 media as we 
described previously [238]. HEK293T cells were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% FBS (BioWest) and 200mm L-glutamine 
(Corning) at 37°C in 5% CO2 atmosphere.  
 
Plasmids and DNA manipulations. 
The ankB gene was cloned into the mammalian expression vector p3XFlag-CMV-10. 
Generation of the 3X-Flag ankB-9L10P, 3X-Flag ankBΔFbox and 3X-Flag-tagged AnkH were 
described previously [176, 238]. The HA-tagged-Trim21 was a kind gift from Dr. Yong-Jun 
Liu at the University of Baylor. The plasmid PXDC61M, which contains the blaM gene 
encoding the mature form of TEM-1 beta-lactamase, was obtained from Dr. Zhao-Qing Luo at 
Purdue University. The ankB gene was PCR amplified with restriction enzymes and cloned in 
frame with the beta-lactamase at the BamHI-XbaI sites to generate a transcriptional fusion 
protein. The resulting plasmid was introduced into L. pneumophila strain AA100/130b and the
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dotA mutant. To verify expression of the fusion proteins in L. pneumophila, strains harboring 
pXDC61M were grown on BCYE containing chloramphenicol, IPTG (0.5mM) and analyzed 
by western blotting. Protein from 1X108 bacteria was transferred to nitrocellulose membranes 
and detected by western blot with a primary monoclonal antibody specific to TEM-1 β-
lactamase (QED Bioscience) and anti-mouse peroxide conjugate as a secondary antibody.   
 
Quantitative Real Time PCR  
Real-time qPCR on attached bacteria was performed as described previously [131, 
177]. Briefly, hMDMs were plated at a density of 5 X 105 in 24 well plates and treated with 1 
µM cytochalasin D for 30 minutes prior to infection. The hMDMs were then infected with WT 
bacteria at a multiplicity of infection (MOI) of 10 for 0, 7.5 or 15 minutes, and intimate and 
synchronized attachment was achieved by centrifugation at 1000rpm for 5 minutes. To assess 
RNA expression levels of ankB, mompS and 16S RNA in response to attachment to hMDMS 
total RNA was extracted from infected cells at the indicated time points using the RNeasy Mini 
Kit (Qiagen, Valencia, CA) as recommended by the manufacturer. Total RNA was treated with 
DNase I (Ambion, Austin, TX) at 37°C for 30 min. Equal amounts of total RNA from infected 
cells were used for cDNA synthesis using Superscript III Plus RNase H reverse transcriptase 
(RT) (Invitrogen, CA) and random primers. Real-time qPCR was done in triplicate using the 
Power SYBR Green PCR Master Mix Kit in a 20 μl reaction volume, as recommended by the 
manufacturer (Applied Biosystems, CA), using specific primers.  The PCR conditions were 2 
min at 94°C initially followed by, 10 sec at 96°C and 20 s at 47°C and 15 s at 72°C for 40 
cycles. Changes in mRNA expression were determined by the comparative CT method 
(threshold cycle number at the cross-point between amplification plot and threshold) and 
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values were normalized to 16S RNA. Negative or positive values were considered as down-
regulation or up-regulation when there was a minimum of two-fold difference of gene 
expression.  
 
Preferential plasma membrane permeabilization and loading of the cytosol with 
antibodies 
Human monocyte-derived macrophages (hMDMs) were isolated and maintained as 
described previously [131]. Monocytes were seeded in 24 well plates at 1X106 cells/well. Cells 
were treated with cytochalasin D (5 µg/ml), an actin polymerization inhibitor, prior to infection 
and throughout the experiment. hMDM plasma membranes were selectively permeabilized for 
5 minutes at room temperature with a RPMI 1640 solution containing digitonin (50 µg/ml) as 
well as anti-AnkB antiserum [135]. Following plasma membrane permeabilization cells were 
extensively washed with media and infected with wild type L. pneumophila as well as the 
ankB, ankB169C/A and dotA mutant strains at a MOI 10 for 15 minutes. Monocytes were 
extensively washed with media and incubated an additional 30 minutes for antibody-antigen 
interaction. Cells were then fixed with 3.7% formaldehyde for 15 minutes at room temperature. 
To ensure cytochalasin D inhibited phagocytosis and bacteria remained extracellular, antibody 
labeling of L. pneumophila with specific rabbit polyclonal anti-serum was performed prior to 
permeabilization, followed by Alexa Fluor 488 donkey anti-mouse secondary antibody. 
(Invitrogen). Cells were then permeabilized with 0.1% Triton X 100 for 10 minutes at room 
temperature, followed by anti-AnkB antiserum detection by Alexa Fluor 555-conjugated 
donkey anti-rabbit IgG (Invitrogen).  
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TEM translocation assay 
The U937 cells were grown in RPMI 1640 containing 10% FBS and seeded in black 
clear- bottom 96 well plates at 1X105 cells/well and treated with phorbol ester (PMA) at 48h 
prior to infection. L. pneumophila strains containing the TEM-1 fusion proteins were grown 
for 3 days on BCYE containing chloramphenicol (5µg/ml) and then streaked on BCYE 
containing chloramphenicol and 0.5 mM Isoprpyl β-D-1-thiogalactopyranoside (IPTG) to 
induce expression of the fusion proteins. Cell monolayers were loaded with the β-lactamase 
substrate CCF4 by adding 20µl of 6X CCF4-AM solution (LiveBLAzerTM-FRET B/G Loading 
Kit, Invitrogen) containing 0.1M probenecid. Cells were incubated with the solution for 2 
hours at room temperature. U937 cells were treated with the actin polymerization inhibitor, 
cytochalasin D (5 µg/mL), for 1hr prior to infection and maintained throughout the infection 
using different MOIs. Plates were centrifuged (300g, 5 min) to initiate bacterial-cell contact 
and incubated at 37°C for 10 minutes. Fluorescence was quantified on a BioTek Synergy HT 
Microplate Reader with excitation at 405nm, and emission was detected at 460nm and 530nm. 
Bacterial effector translocation was determined by the emission ratio 460nm/530nm to 
normalize the β-lactamase activity to non-infected substrate loaded cells.  
 
Recruitment of host farnesylation and ubiquitination machinery to sites of L. 
pneumophila attachment. 
A total of 5 X 105 hMDMs on glass coverslips in 24 well plates were pretreated for 30 
minutes with cytochalasin D (5 µg/ml) and then infected with wild type L. pneumophila and 
the ankB and dotA mutants at an MOI of 10 for 15 minutes. Processing of infected cells for 
confocal microscopy was performed. Briefly, fixed and permeabilized cells were blocked for 
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1h with 3% BSA-PBS and then mouse anti-L. pneumophila anti-serum (1/1000 dilution), and 
anti-Skp1, anti-Cul1, anti-FTα, anti-RCE1 and anti-IcmT antibodies (1/200 dilution) (Abcam, 
Cambridge, MA) were added to 3% BSA-PBS and incubated at room temperature for 1h. 
Following extensive washing with 3% BSA-PBS, bound antibodies were detected with Alexa 
Fluor 488 or 555-conjugated donkey anti-rabbit or mouse IgG antibodies (Invitrogen, 
Carlsbad, CA) for 1h. Following this, the glass cover slips were mounted on glass slides using 
ProLong Gold anti-fade reagent (Invitrogen, Carlsbad, CA). The fixed cells were examined 
with an Olympus FV1000 laser scanning confocal microscope as described previously [238]. 
On average, 8-15 0.2 um serial Z sections of each image were captured and stored for further 
analyses, such as cropping and centering the images, using Adobe Photoshop CS5. 
 
Gas Chromatography-Mass Spectrometry analyses of free amino acids   
The cellular levels of free amino acids was determined as part of the global 
metabolomics profile. The hMDMs cells were seeded in 6 well plates at 1 X 106 and prior to 
infection the cells were treated with 1 µM cytochalisin D for 30 minutes. The hMDMs were 
infected with WT or ankB mutant L. pneumophila at an MOI of 100 for 1h and the infected 
cells were lysed in aqueous 90% methanol. Lysates were stored at -20°C for 1h and then 
centrifuged (21000 x g at 4°C) for 10 min. The resulting supernatants were dried using a Speed-
Vac and prepared for GC-MS. 
All GC-MS analysis was performed at the University of Utah Metabolomics core 
facility using a Waters GCT Premier mass spectrometer fitted with an Agilent 6890 gas 
chromatograph and a Gerstel MPS2 autosampler. The dried samples were suspended in 40 µL 
of a 40 mg/mL O-methoxylamine hydrochloride in pyridine and incubated for one hour at 
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30°C. A 25 µL sample of this solution was transferred to auto-sampler vials followed by the 
addition of N-methyl-N-trimethylsilyltrifluoracetamide and further incubated for 30 minutes 
at 37°C with shaking. A 1 µL sample was injected to the gas chromatograph inlet in the split 
mode set to a 10:1 ratio. Injector temperature was held at 250°C. The gas chromatograph had 
an initial temperature of 95°C for one minute followed by a 40°C/min ramp to 110°C with a 
hold time of 2 minutes. This was followed by a second 5°C/min ramp to 250°C then a third 
ramp to 350°C and a final hold time of 3 minutes. A 30 m Restek Rxi-5 MS column with a 5 
m long guard column was employed for analysis. Data were collected by MassLynx 4.1.   Data 
analysis for free cellular amino acids was performed using QuanLynx which quantified the 
area under the curve for each amino acid. All data was saved to an Excel spread sheet for 
further analysis. This analysis includes most of the amino acids, but His is difficult to detect 
and Cys makes disulfide bonds with proteins and is also difficult to detect. In our samples, Arg 
and Asn were not detectable by the methodology used. The GC-MS analysis gives relative 
results of the area under the curve for the same amino acid, and is not quantitative relative to 
other amino acids within the same sample. Since the GC-MS analyses compare levels of the 
same metabolite/amino acid between different samples/treatments, the results are presented as 
a ratio of infected/un-infected cells.  
 
..Legionella-containing vacuole purification 
 A total of 6 X 108 U937 macrophages were plated in T175cm flask in 60ml RPMI 
media supplemented with 10% FBS. At a multiplicity of infection of 50 bacteria per 
cell Legionella containing vacuoles were formed by internalization of bacteria diluted 
in 20ml RPMI media. Internalization of the bacteria was performed for 30min at 37˚C 
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under 5% CO2. Cells were washed 3X in PBS and then incubated in growth media for 
4hrs at 37˚C under 5% CO2. After 4hrs cells were washed 3X in PBS (4˚C) and scraped 
into a 50ml screw cap centrifuge tube and pelleted at 4˚C for 5min at 450g. Cells were 
resuspended in homogenization buffer (250mM sucrose, 20mM Hepes/KOH (pH7.2) 
+0.5mM EGTA (pH 8.0)) and pelleted by centrifugation at 675g for 6 minutes at 4˚C. 
Cells were then resuspended in homogenization buffer with protease inhibitors (Roche 
cocktail) at 2X10^8/ml. Cells were lysed with a dounce homogenizer on ice and 
visualized under light and confocal microscopy to ensure effective cell lysing and 
Legionella vacuole integrity. Whole cells and nuclei were then pelleted in an1.5ml tube 
for 3.5min at 344g. The supernatant was placed in a new 1.5ml tube and centrifuged for  
3.5min at 344g resulting in the post nuclear supernatant (PNS). The PNS was brought 
to a final concentration of 39% sucrose. The sucrose solutions for the step gradient 
were made in w/v in 20mM Hepes /KOH (pH 7.2). The sucrose step gradient was made 
by layering the PNS (39% sucrose) onto 2ml 55% sucrose layered onto 1ml 65% 
sucrose in a 14mm X 89mm Beckman ultracentrifuge tube. We then layered 2ml 10% 
sucrose onto 2ml 25% sucrose solution onto the PNS. The sucrose gradient was 
centrifuged for 1hr at 100,000g at 4˚C in a swinging bucket rotor (Beckman SW41). 
The LCVs were isolated from the 55%-65% interface using a 16g needle and not 
disturbing any other fraction. LCVs were placed into 10ml PBS (4˚C) and centrifuged 
at 40,000g (SW41) for 30min at 4˚C. Pelleted LCVs were solubilized in 1% Triton X-
100 in PBS for 30 minutes on ice. Following centrifugation at 10,000g for 5 minutes to 
pellet bacteria, the supernatant containing eukaryotic proteins associated with the LCV 
was stored at -80˚C.  
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…Antibodies and Confocal Microscopy for LCV isolation 
 Isolated LCVs were plated onto 24 well coverslips pretreated with poly-L-lysine 
and allowed to adhere for 1 hr. Extravacuolar L. pneumophila were labeled with a 
rabbit anti- L. pneumophila antibody prior to permeabilization for 1 hr. LCVs were then 
permeabilized with methanol (-20˚C) for 5 minutes, blocked with 3% BSA for 1 hr and 
then labeled with a mouse anti-L. pneumophila antibody for 1 hr. Secondary antibodies 
used were Alexa Flour goat anti-mouse 488 and Alexa Flour goat anti-rabbit 555. 
Polyubiquitinated proteins present on the LCVs were labeled with a mouse anti-
polyubiquitin antibody (Enzo Life Sciences) for 1hr prior to vacuole membrane 
permeabilization and visualized with Alexa Flour goat anti-mouse 488.  
 
Protein Digestion for Mass Spectrometry 
For Mass Spectrometry analysis, TCA precipitated proteins were resuspended in 
8M urea, 50mM Tris pH 8.5. Resuspended peptides were diluted 1:1 with 50mM Tris 
pH 8.5 to lower the urea concentration to 4M prior to digestion with endoproteinase 
Lys-C (10ng/uL) for 8hrs. Digestions were further diluted 4:1 with 50mM Tris pH 8.5 
to lower the urea concentration to 1M urea prior to digestion with trypsin (5ng/uL) for 






   Ubiquitinated Protein immunoprecipitation for ubiquitinated LCV proteome 
analysis 
Ubiquitinated peptides were immunoprecipitated using ubiquitin motif 
immunoaffinity beads (Cell Signaling Technology) as recommended by the 
manufacturer with the following modifications [242]. Desalted peptides were dissolved 
in 1.0-1.4 mL of IAP buffer (50 mM MOPS-NaOH, pH 7.2, 10 mM Na2HPO4, 50 mM 
NaCl). The pH was adjusted to 7.2 with 1M NaOH.  The peptide solution was cleared 
by centrifugation for 5-10 min at 13,200g. The supernatant was transferred to a new 
tube and cooled on ice for 10 minutes. The cooled peptide solution was transferred to 
the tube with the antibody beads and incubated on a rotator at 4˚C for 60 min. The 
beads were washed 4 times with 1mL IAP buffer, followed by 1 wash with 1mL water. 
The peptides were eluted from the beads by adding 55µl 5% Formic Acid (FA), mixed 
and incubated at room temperature for 10 min. The beads and elution buffer were 
transferred to a Teflon spin column and the eluate was collected by centrifugation. The 
beads were washed with 45µl 0.1% TFA and combined with the first eluate [242]. The 
peptides were desalted using StageTips [243] and nanoLC-MS2 data was collected. 
  
nanoLC-MS2 data collection 
In collaboration with Dr. Steve Gygi, Dr. Ryan Kunz and Ross Tomaino at the 
Harvard University Taplin Mass Spectrometry Facility mass spectrometry data were 
collected on an Orbitrap Fusion mass spectrometer equipped with an easy nano-LC 
1000 for sample handling and liquid chromatography. Peptides were separated on a 75 
µm x 30 cm hand-pulled fused silica microcapillary column with a needle tip diameter 
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less than 10 µm and packed with 1.8 μm 120Å GP-C18 beads from Sepax Technologies 
Inc. The column was equilibrated with buffer A (3% ACN + 0.125% FA). Peptides 
were loaded onto the column at 100% buffer A. Separation and elution from the column 
was achieved using a 90 min 3-25% gradient of buffer B (100% ACN + 0.125% FA). 
Survey scans of peptide precursors from 400 to 1400 m/z were performed at 120K 
resolution (at 200 m/z); AGC, 50k; max injection time, 100ms; monoisotopic precursor 
selection turned on; charge state, 2-6; dynamic exclusion, 45s with a 10 ppm tolerance. 
Tandem MS was performed in top speed mode (2 second cycles) starting with the most 
intense precursor having an intensity greater than 5k. Parent ions were isolated in the 
quadrupole (0.7 m/z isolation window). Collision induced dissociation was performed 
in the ion trap with a rapid scan rate; 35% collision energy; AGC, 10k; max injection 
time, 35ms; parallelizable time was turned on. 
 
Mass spectrometry data analysis 
 A suite of in-house software tools, created by Dr. Steve Gygi, was used for .RAW 
file processing, controlling peptide and protein false discovery rates, and assembling 
peptide level data into protein level data [242, 244]. The MS/MS spectra were searched 
using the SEQUEST algorithm [245] against a composite protein database consisting of 
all protein sequences from the Uniprot human database (88,501 proteins) along with 
common contaminating proteins (111 proteins) in both the forward and reverse 
direction. Sequest parameters used to search the MS data were: precursor tolerance, 
50ppm; fragment ion tolerance, 1Da; fully tryptic; 2 missed cleavages; variable 
modifications of oxidized methionine (15.9949 Da), alkylation of cysteine (57.0214), 
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and diGlycine motif on lysine (114.0429). A target-decoy strategy was used to 
determine false discovery rates [246]. The peptide-level false discovery rate was 
restricted to <1% by using linear discriminate analysis based on several different 
SEQUEST parameters including Xcorr≥1.0, deltaXcorr, charge state, and a minimum 
peptide length of 7 amino acids [244]. An algorithm similar to Ascore was used for 
diGlycine localization and site quantification [242, 247]. The localization score is based 
on the Ascore algorithm, where a localization score ≥19 indicated >99% certainty in 
site localization [247]. Protein identifications for the complete proteome of the WT 
strain and ankB mutant strain are based on at least 2 unique peptides.  
 
MetaCore Software Analysis 
MetaCore is an integrated software suite for functional analysis of various aspects 
of screening data [248, 249]. MetaCore software determines the most significant 
relationships among the proteins analyzed such as Pathway Maps, GO Processes, Process 
Networks and Metabolomic Networks. For our analysis the software determined the most 
significant relationships shared among the WT strain LCV proteome and a separate 
analysis for the ankB mutant strain. MetaCore software is available online and was 
obtained through the University of Louisville license. The excel spreadsheet containing 
the complete WT strain LCV proteome and the ankB mutant stain LCV proteome were 





Transfection of HEK293T cells. 
The ankB gene was cloned into the mammalian expression vector p3XFlag-CMV-10. 
Generation of the 3X-Flag ankB-9L10P, 3X-Flag ankBΔFbox and 3X-Flag-tagged AnkH 
were described previously [176, 238]. The HA-tagged-Trim21 was a kind gift from Dr. 
Yong-Jun Liu at the University of Baylor. HEK293T cells were grown to ~70% 
confluency and plated onto poly-L lysine treated 6 well plates. Following 24 h incubation 
HEK293T cell monolayers were transfected with ~2ug plasmid DNA/well using 
polyethylenimine (Polysciences) for 24 h.  
 
Cycloheximide inhibition 
HEK293T cells plated in 6 well plates were transfected with 3XFlag-AnkB for 24 
hr. The proteasomal inhibitor MG132 (Selleckchem) used at 20uM was added to the 
indicated cells 2 hours prior to cycloheximide treatment at 100ug/ml. At indicated time 
points cells were lysed and subjected to SDS-PAGE and immunoblotting with anti-Flag 
and anti-actin antibodies. 
 
In vivo co-immunoprecipitation  
HEK293T cells were transfected with3X-Flag AnkB, AnkB9L10P, AnkBΔFbox, 
AnkH, HA-tagged Trim21 for 24 hr and collected in lysis buffer containing 50 mM Tris 
pH 7.4, 0.25M NaCl, 0.5% Triton X-100, 1mM EDTA, 50mM NaF, 0.1mM Na3VO4 and 
EDTA-free protease inhibitor cocktail (Roche). Flag-tagged and HA-tagged proteins were 
immunoprecipitated using anti-Flag M2 agarose (Sigma) or anti-HA affinity gel (Sigma) 
according to the manufacturer’s instructions.  
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Antibodies and Western Blot 
Immunoprecipitated proteins were heated at 99°C for 5 minutes in sample buffer 
(Pierce) and separated by 10.4-15% SDS-PAGE electrophoresis and transferred to a 
PVDF membrane. Anti-Flag (Sigma) used at 1:1000, anti-actin (Proteintech) used at 
1:15000, anti-ubiquitin (Cell Signaling) used at 1:1000, anti-K48 ubiquitin (Cell 
Signaling) used at 1:1000, anti- K63 ubiquitin (Cell Signaling) used at 1:1000, anti-M45 
used at 1:50 were incubated overnight in 5% milk at 4°C. Anti-HA (Cell Signaling) was 




Section 1. Rapid Nutritional Remodeling of Macrophages 
Upon Attachment of Legionella pneumophila 
 
Triggering transcription of ankB upon attachment of L. pneumophila to human 
macrophages 
 Upon entry of the ankB mutant to macrophages or amoeba, it exhibits a dramatic 
starvation response and differentiation into the non-replicative phase, but both phenotypes are 
circumvented by amino acids supplementation [86]. Similar phenotypes are also exhibited by 
the WT strain upon entry into proteasome-inhibited cells, and in both cases the respective 
phenotypes are circumvented upon supplementation of amino acids [86]. L. pneumophila is 
auxotrophic for seven amino acids, therefore, acquisition of host cell amino acids is critical to 
provide the carbon and energy needed during intracellular replication [250]. Previous data 
indicates AnkB as the major contributor to host amino acid retrieval, therefore, translocating 
AnkB upon intimate attachment with the host cell will increase the host cell amino acid levels 
prior to LCV formation [86]. Investigating the function of AnkB from attached extracellular 
bacteria can lead clues into how L. pneumophila manipulates the host cell polyubiquitination 
machinery to increase the host amino acid levels prior to bacterial entry.   
We tested the hypothesis that WT L. pneumophila likely employs AnkB during initial 
stages of interaction with the host cell to circumvent the amino acids starvation response and 
the associated phenotypic modulations. We determined whether attachment of L. pneumophila 
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to host cells triggered transcription of AnkB. To determine this, human monocytes-derived 
macrophages (hMDMs) were pre-treated with cytochalasin D for 30 minutes to block 
phagocytosis and then infected with WT L. pneumophila at an MOI of 10 for 0, 7.5 and 15 
minutes. This bacterial attachment protocol resulted in attachment of 1-2 bacteria/ cell in ~50% 
of the cells in the monolayers. Block of bacterial entry into hMDMs by cytochalasin D was 
confirmed by treatment of the infected cytochalasin D-treated monolayers by gentamicin, 
indicating that the bacteria were extracellular [86]. Following RNA purification and cDNA 
synthesis, expression of the ankB gene was determined by Real-Time qPCR using expression 
of the 16S RNA as an internal control, as we described previously [131, 176, 251]. Expression 
of the constitutively expressed mompS gene was used as a control.  Compared to expression of 
ankB at 0 minutes post-attachment, its expression was increased by 9-fold and 26-fold at 7.5 
and 15 minutes, respectively, post-bacterial attachment (Fig. 1). During the course of the 
attachment experiment no change was observed in expression of mompS (Fig. 1). These data 
show that transcription of ankB is triggered immediately upon attachment of L. pneumophila 






Figure 1: Expression of ankB upon intimate attachment to hMDMs. Quantitative Real-
Time PCR of ankB gene transcription by L. pneumophila at 0, 7.5 and 15 minutes post-
attachment to hMDMs.  The hMDMs were pre-treated with cytochalasin D and infected for 
the indicated time periods followed by total isolation of RNA and RT-PCR. Transcription of 
ankB, or the control gene mompS was normalized to 16S RNA levels. Fold changes in gene 
expression were compared to levels measured at time 0 minutes. Error bars indicate SEM.  The 




Translocation of AnkB into macrophages upon bacterial attachment 
To determine temporal and spatial translocation of AnkB upon intimate attachment of 
L. pneumophila to macrophages, we generated a L. pneumophila strain expressing a β-
lactamase-AnkB reporter fusion construct to monitor real-time translocation in cells pre-loaded 
with the CCF4 fluorometric β-lactamase substrate [132]. The human macrophage U937 cell 
line preloaded with CCF4 was pretreated with cytochalasin D, and then infected with L. 
pneumophila expressing β-lactamase fusions at various MOIs for 15 minutes (Fig. 2). 
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Hydrolysis of CCF4 was measured by quantifying blue (460nm) and green (530nm) 
fluorescence emission, and is reported as the 460nm/530nm ratio where a ratio greater than 1 
represents positive translocation. The data showed that AnkB was equally translocated into 
untreated or cytochalasin D-treated U937 macrophages. Translocation of AnkB by attached 
extracellular bacteria was completely dependent on a functional Dot/Icm T4SS, since the dotA 
translocation-defective mutant failed to translocate the effector (Fig. 2). As expected, 
increasing the MOI resulted in increased AnkB translocation in a dose-response manner, as 
evident by greater CCF4 hydrolysis (Fig. 2). No translocation was detected for the fatty acid 
biosynthetic enzyme, enoyl-CoA reductase (FabI), which was used as a negative control (Fig. 
2) [132]. These data show that attachment of L. pneumophila to macrophages triggers rapid 








































Figure 2: Translocation of βlactamase -AnkB fusion protein by L. pneumophila upon 
intimate attachment to U937 cells. Cytochalasin D-treated U937 cells were infected with 
increasing MOIs of L. pneumophila strains expressing various βlactamase-fusion constructs 
and translocation was measured by monitoring hydrolysis of the fluorogenic substrate CCF4. 
A 460nm/530nm ratio greater than 1 indicates translocation of the fusion construct. Data 




Host-mediated farnesylation and anchoring of AnkB to the cytosolic side of the plasma 
membrane beneath attachment sites of extracellular bacteria 
We decided to determine the cellular location of the native AnkB effector injected by 
attached extracellular bacteria. Using anti-AnkB antiserum on cytochalasin D-treated infected 
cells to detect cellular location of AnkB injected by attached extracellular bacteria was difficult 
to interpret by confocal microscopy. This was due to our findings that the injected AnkB was 
not detected in the cytosol but seemed to be localized beneath the attached extracellular WT 
bacteria, which also bound the anti-AnkB antibody. The resolution was not sufficient to 
differentiate injected AnkB localized intracellularly beneath bacterial attachment from AnkB 
contained in the attached extracellular bacteria.  Since the β-lactamase-AnkB reporter fusion 
was clearly injected by attached extracellular bacteria (Fig. 2), our microscopy findings 
suggested that the injected AnkB was likely localized exclusively beneath bacterial attachment 
sites.     
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To overcome the above mentioned caveat and to determine whether the injected native 
AnkB by attached extracellular bacteria was located beneath bacterial attachment sites, the 
cytosol of live hMDMs was pre-loaded with anti-AnkB antibodies prior to bacterial 
attachment. This would allow the antibody to bind AnkB upon its injection by attached 
extracellular bacteria [252-254]. This strategy also provides a clear and more solid 
interpretation of the data, since the anti-AnkB antibody is loaded to the host cell cytosol prior 
to inoculation of the bacteria. To load the host cell cytosol with the anti-AnkB antibodies prior 
to infection, the plasma membrane of live hMDMs was preferentially permeabilized with a 
low concentration of digitonin [252-254]. After loading the cells with the antibody and 
allowing the cells to heal the membrane damage for a few minutes, integrity of the plasma 
membrane was confirmed by impermeability to Trypan blue (data not shown). Without 
digitonin treatment, the plasma membrane of hMDMs was impermeable to anti-AnkB 
antibodies, as expected (Fig. 3). The antibody-loaded hMDMs were treated with cytochalasin 
D to prevent phagocytosis and then infected at a MOI of 10 with WT L. pneumophila or the 
isogenic mutants, dotA or ankB.  The cells were then fixed and processed for confocal 
microscopy. This bacterial attachment protocol resulted in an average attachment of 1-2 
bacteria/ cell in ~50% of the cells in the monolayers. To allow differentiation between 
extracellular and intracellular bacteria, extracellular L. pneumophila were labeled with specific 
antibodies prior to permeabilization of the infected cells. When the hMDMs were 
permeabilized with digitonin and loaded with anti-AnkB antibodies, the loaded antibody was 
detectable as red patches throughout the cytosol of ~98% of the cells, indicating successful 
loading of the cells with anti-AnkB antibodies to prior to infection (Fig. 3). When hMDMs 
were infected with wild type L. pneumophila, 52% of attached extracellular bacteria co-
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localized with AnkB exclusively beneath the site of bacterial attachment (Fig. 3). The 48% of 
extracellular bacteria that do not not co-localize with anti-AnkB could be due to the low 
amount of AnkB translocated, the level of antibody detection, or the bacteria not yet 
translocating AnkB into the cell. In addition, AnkB must be farnesylated to anchor into the 
plasma membrane beneath attached extracellular bacteria, therefore, multiple biological and 
technical reasons can account for the 48% of extracellular bacteria that lack co-localization to 
the site of extracellular bacterial attachment. As expected, the dotA translocation-defective 
mutant and the ankB mutant did not co-localize with AnkB (5% and 0% respectively) (Student 
t-test, P<0.007 and 0.003, respectively) (Fig. 3).   
Since AnkB is hydrophilic and its anchoring to the LCV membrane is mediated by host 
farnesylation within amoeba and macrophages [135, 255], we determined whether host 
farnesylation was required for the exclusive localization of AnkB to the cytosolic side of the 
plasma membrane beneath the sites of bacterial attachment. The cytosol of hMDMs was pre-
loaded with anti-AnkB antiserum prior to infection, as described above. Cytochalasin-D treated 
cells were infected by the farnesylation-defection ankB-169C-A substitution mutant in the CaaX 
motif, which has been shown to be translocated into the host cell [135]. The data showed that 
infection by the ankB-169C-A substitution mutant resulted in failure to anchor AnkB to the 
plasma membrane beneath bacterial attachment sites (Student t-test, P<0.005) (Fig. 3). 
Therefore, host farnesylation anchors the injected AnkB by attached extracellular L. 
pneumophila to the cytosolic side of the plasma membrane directly and exclusively beneath 
bacterial attachment sites. This is the first demonstration of farnesylation-mediated anchoring 





Figure 3: Anchoring of native AnkB injected by attached L. pneumophila to the cytosolic 
side of the plasma membrane of hMDMs beneath bacterial attachment sites.  
Representative confocal microscopy images of cytochalasin D-treated infected hMDMs that 
were preloaded with anti-AnkB antisera (red) in the absence of (A) or presence (B) of digitonin.  
The hMDMs were infected by L. pneumophila strains (green) for 15 minutes. The numbers in 
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the merged images of all panels are mean and standard deviation of the frequency of anchoring 
AnkB to the plasma membrane beneath attached extracellular bacteria. The data represent 




Recruitment of the host farnesylation machinery to the plasma membrane beneath 
attached extracellular L. pneumophila 
 Since during infection host-mediated farnesylation of AnkB anchors it to the LCV 
membrane, and AnkB was exclusively localized beneath bacterial attachment sites, we tested 
the hypothesis that the host-farnesylation enzymes FTase, IcmT and RCE1 were recruited to 
the plasma membrane by attached extracellular bacteria to anchor AnkB to the plasma 
membrane. Cytochalasin D-treated hMDMs were infected with wild-type L. pneumophila and 
the isogenic mutants ankB and dotA at an MOI of 10 for 15 minutes. The cells were then 
immediately fixed and processed for confocal microscopy to determine if FTase, IcmT and 
RCE1 were recruited beneath the sites of bacterial attachment. The data showed that FTase, 
IcmT and RCE1 were all recruited beneath attachment sites of wild-type bacteria at a frequency 
of ~85% (Fig. 4A, B, C). In contrast, FTase, IcmT and RCE1 were recruited at a frequency of 
only ~10%, beneath attachment sites of the dotA mutant (Student t-test, P<0.006, 0.007, 0.006, 
respectively) (Fig. 4). FTase, IcmT and RCE1 were recruited at a significantly reduced 
frequency of 43, 47 and 41%, respectively (Student t-test, P<0.01), beneath attachment sites 
of the ankB mutant bacteria (Fig. 4). The moderate reduction in recruitment of the host 
enzymes by the ankB mutant is most likely due to the fact that the other ~12 farnesylated 
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effectors of Legionella injected by the ankB mutant [200, 256] interact with the host 
farnesylation enzymes, while the translocation-defective dotA mutant is severely defective in 
recruitment of the host enzymes [135]. These data indicate that upon attachment of L. 
pneumophila the Dot/Icm apparatus is essential for recruitment of the host enzymes into the 
plasma membrane beneath the sites of bacterial attachment. This is the first example of 
recruitment of the host farnesylation machinery by attached extracellular bacteria to anchor an 





Figure 4: The farnesylation machinery components, FTα, RCE1 and IcmT are recruited 
beneath attachment sites of L. pneumophila to hMDMs.  The hMDMs pre-treated with 
cytochalasin D were infected by the wild-type (WT) L. pneumophila and the isogenic dotA or 
ankB mutants for 15 minutes. Representative confocal microscopy images of infected hMDMs 
cells showing co-localization of (A) FTα, (B) RCE1 and (C) IcmT proteins to attached WT, 
ankB or dotA bacteria. Bacteria were labeled with anti-Lpn antibody (green) and FTα, RCE1 
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or IcmT were labeled with the respective specific antibodies (red) and then analyzed by 
confocal microscopy. The arrowheads indicate intense co-localization of FTα , RCE1 or IcmT 
with the WT strain. The numbers in the merged images of all panels are mean and standard 
deviation of the frequency of recruitment of FTα , RCE1 or IcmT beneath attached extracellular 
bacteria.  The data represent analyses of 100 infected cells and are representative of three 




Recruitment of the host SCF1 ubiquitin ligase complex beneath attached extracellular     
L. pneumophila 
 During ectopic expression, the AnkB effector interacts with the host Skp1 component 
of the SCF1 E3-ubiquitin ligase complex, but the location of this interaction during infection 
is not known [238, 239]. Since AnkB is exclusively localized to the Legionella-containing 
vacuole (LCV) membrane during infection and to the plasma membrane beneath attached 
extracellular L. pneumophila, we tested the hypothesis that the SCF1 ubiquitin ligase was 
recruited to the LCV where it interacts with AnkB and that this recruitment was rapidly 
initiated at the plasma membrane beneath bacterial attachment sites. To determine recruitment 
of SCF1 to the LCV, hMDMs were infected at an MOI of 10 for 1h with wild-type L. 
pneumophila or the ankB or dotA translocation-defective isogenic mutant. The data showed 
that both Skp1 and Cul1 components of the SCF1 were recruited to the LCV of the WT strain 
at a frequency of 82-84% (Fig. 5).  Recruitment of both host cell components was dependent 
of a function Dot/Icm translocation system, since the dotA translocation-defective mutant was 
severely defective in this recruitment (Fig. 5). To determine whether recruitment of the SCF1 
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components was initiated by attached extracellular bacteria, cytochalasin D-treated hMDMs 
were infected at an MOI of 10 for 15 minutes. Gentamicin treatment of cytochalasin D-treated 
control cells sterilized the monolayer, which confirms effectiveness of blocking bacterial entry 
by cytochalasin D (data not shown). The cells were fixed immediately and processed for 
confocal microscopy. The data showed that Skp1 and Cul1 were recruited beneath bacterial 
attachment sites at a frequency of ~80%. This recruitment was dependent on a functional 
Dot/Icm type IV secretion system, since Skp1 and Cul1 were recruited at a frequency of only 
~10% by attached translocation-defective dotA mutant bacteria (Student t-test, P<0.008) (Fig. 
5). Only 34 and 30% of attached ankB mutant bacteria recruited Skp1 and Cul1, respectively 
(Fig. 5), which was significantly less than wild-type bacteria (Student t-test, P<0.01). These 
data show that the Dot/Icm translocation system of L. pneumophila is essential for recruitment 
of the SCF1 ubiquitin ligase to the LCV and that this recruitment is initiated at the plasma 
membrane beneath sites of bacterial attachment. This is the first example of recruitment of the 
host SCF1 to a pathogen-containing vacuole and the initiation of this process at the cytosolic 




Figure 5: Recruitment of the SCF ubiquitin ligase components Skp1 and Cul1 beneath 
attachment sites of L. pneumophila to hMDMs and the LCV.  Untreated (A) or cytochalasin 
D pre-treated (B) hMDMs were infected by the wild-type (WT) L. pneumophila and the 
50 
isogenic dotA or ankB mutants for 2 hours (A) or 15 minutes (B), followed by fixation and 
processing for confocal microscopy. Representative confocal microscopy images of infected 
hMDMs cells show co-localization of Skp1 and Cul1 proteins (red) with the LCV (green) (A) 
and with attached extracellular L. pneumophila (B). The arrowheads indicate intense co-
localization of Skp1 or Cul1 with the WT bacteria. The numbers in the merged images of all 
panels are quantification of the frequency of recruitment of Skp1 or Cul1 beneath attached 
extracellular bacteria. The data represent analyses of 100 infected cells and are representative 




Elevated levels of cellular amino acids triggered by attached extracellular L. pneumophila 
 The ultimate function of the LCV membrane-anchored AnkB effector is to generate 
high levels of cellular amino acids through host proteasomal degradation of K48-linked 
polyubiquitinated proteins [86]. Therefore, we determined whether the injected AnkB by 
attached extracellular L. pneumophila resulted in elevated levels of cellular amino acids 
through degradation of the polyubiquitinated proteins assembled beneath bacterial attachment 
sites [238]. To achieve this, cytochalasin D-treated hMDMs were infected by the wild-type 
strain or the isogenic ankB mutant L. pneumophila.  Trypan blue straining of the cells showed 
that there was no detectable effect of cytochalasin D on permeability of the plasma membrane 
(data not shown). The hMDMs were lysed and the relative levels of free amino acid were 
determined by GC-MS. The data showed that attached wild-type L. pneumophila triggered a 
rapid rise in the levels of amino acids, relative to uninfected cells (Student t-test, p <0.001) 
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(Fig. 6). In contrast, attachment of the ankB mutant bacteria to hMDMs did not alter cellular 
levels of amino acids relative to uninfected cells (Fig. 6). A detailed working model of AnkB-
dependent nutritional preparation of the host cell is shown, which depicts the translocation, 
rapid farnesylation and polyubiquitination of the AnkB targets directly beneath the attachment 
sites of extracellular bacteria (Fig. 7). Thus, translocation of AnkB by attached extracellular L. 
pneumophila results in increased levels of cellular amino acids, which are needed to block a 
potential starvation response and differentiation of L. pneumophila into the non-replicative 
phase (Fig. 7). This is the first example of a strategy by an intracellular pathogen to trigger 
rapid nutritional remodeling of the host cell upon attachment to the plasma membrane, and as 
a result, a gratuitous surplus of cellular amino acids is generated to support proliferation of the 
incoming pathogen. In addition, the AnkB-dependent increase in free cellular amino acids can 







Figure 6: Intimate attachment of L. pneumophila to hMDMs triggers an increase in 
cellular levels of free amino acids. The hMDMs pre-treated with cytochalasin D were 
infected for 15 min, followed by preparation of cellular lysates and determination of the 
relative levels of cellular amino acids by GC-MS. Amino acid levels are expressed as the fold 
ratio of infected/uninfected hMDMs. The analyses were performed in triplicates, and the data 
shown are one of three representative experiments. The data represent analyses of 100 infected 
cells and are representative of three independent experiments.   
 
 
Fold Ratio of Amino Acid Levels 
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Figure 7: A working model of AnkB-mediated nutritional preparation of the host cell 
by attached extracellular L. pneumophila. Upon bacterial attachment, the Dot/Icm 
translocation system is triggered to inject bacterial effectors, one of which is AnkB.  The host 
farnesylation enzymes are recruited beneath bacterial attachment sites and are essential for 
farnesylation of AnkB, which enables anchoring this effector to the cytosolic side of the 
plasma membrane beneath bacterial attachment sites.  The host SCF1 ubiquitin ligase 
complex is recruited to the plasma membrane where it interacts with the F-box domain of 
AnkB to trigger assembly of K48-linked polyubiquitinated proteins beneath bacterial 
attachment sites.  Proteasomal degradation of the K48-linked polyubiquitinated proteins 
generates higher levels of cellular amino acids, particularly the limiting ones, such as 
cysteine, which is a metabolically preferable source of carbon and energy for L. 
pneumophila.  The availability of higher levels of cell amino acids upon entry of L. 
pneumophila circumvents the entering bacterium from a potential starvation response and 
differentiation into the motile non-replicative phase.  The elevated cellular levels of amino 
acids trigger differentiation of L. pneumophila into the replicative phase and are main sources 




Discussion Section 1 
L. pneumophila has acquired a large array of eukaryotic-like proteins possibly 
through horizontal gene transfer through evolution with protozoan host [137, 138]. While 
~300 effectors are translocated through the Dot/Icm type IVB secretion system, intracellular 
replication of L. pneumophila strain AA100/130b and the Paris stain is dependent upon the 
bona fide F-box effector AnkB [131, 239]. This unique ability for a single effector to dictate 
the fate of intracellular survival shows the importance to characterize the function of AnkB 
during infection. L. pneumophila utilizes AnkB, which interacts with the SCF1 E3 ubiquitin 
ligase complex to trigger K48-linked polyubiquitination that are targeted for proteasomal 
degradation. This increases the levels of free cellular amino acids above the threshold needed 
for intracellular replication [86]. This increase in free cellular amino acids is crucial to 
prevent a starvation response and differentiation into the non-replicative phase [86]. When 
the host cell proteasomes are inhibited WT L. pneumophila undergoes a starvation response, 
similar to the ankB mutant strain, that can be reversed through the addition of amino acids 
into the cell culture medium [86].We have shown AnkB is translocated from attached 
extracellular bacteria, where it anchors directly beneath attached extracellular bacteria 
through host-mediated farnesylation of the CAAX motif in the C-terminus of AnkB [241]. 
The K48-linked polyubiquitinated proteins surrounding the LCV have been observed 
throughout the infection, therefore unlike some Dot/Icm effectors such as RalF and SidC, 
AnkB is functional throughout the infection [257, 258].  
The translocation of AnkB from attached bacteria shows a necessity for the 
immediate increase of amino acid sources, which provides the carbon and energy required for 
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intracellular replication. While it is not uncommon for L. pneumophila effectors to be 
translocated from attached extracellular bacteria, this has only been shown for a relatively 
small number of the ~300 effectors [258]. Interestingly, AnkB is the only ankyrin effector 
shown to be translocated from attached bacteria when seven L. pneumophila ankyrin 
effectors were analyzed [176]. It is possible that L. pneumophila translocates a subpopulation 
of the effectors upon bacterial attachment that are needed for critical aspects of infection, 
such as early LCV maturation and nutrient acquisition. Due to the biphasic life cycle of L. 
pneumophila, which uses nutrient deprivation as a major signal for switching from the 
replicative phase to the transmissive phase, the immediate AnkB-dependent increase in free 
cellular amino acids can be easily justified. When the AnkH and AnkJ effectors are deleted, 
there is a slight defect in intracellular replication, however neither are translocated upon 
attachment [176]. Future studies investigating effector translocation kinetics will provide 
crucial details to how L. pneumophila determines when certain effectors are translocated.  
The host cell ubiquitination and farnesylation machinery are recruited within 15 
minutes to the sites of extracellular bacterial attachment. While AnkB is the only CaaX motif 
containing effector shown to be translocated upon bacterial attachment, some of the other 
CaaX motif containing effectors are also probably translocated upon attachment, since ~40% 
of the ankB mutant strain attached extracellular bacteria recruit the host cell farnesylation 
machinery enzymes FTα, RCE1 and ICMT. The recruitment of host farnesylation machinery 
is critical for the function of AnkB, since farnesylation of AnkB is required in order to 
anchor into the cytosolic face of the LCV membrane [135] and to function as a platform for 
the recruitment of K48-linked polyubiquitinated proteins to the LCV. L. pneumophila is the 
only intracellular pathogen known to recruit the farnesylation enzymes to the point of 
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extracellular bacterial attachment, as well as to the LCV, to allow anchoring of bacterial 
effector proteins. Interestingly, the Salmonella effectors Ssel and SspH2 are S-palmitoylated, 
through the addition of a lipid moiety to the effector, which enables the effector to alter its 
sub-cellular localization by anchoring into the plasma membrane [259]. Similar to AnkB, this 
host-mediated post-translational lipidation is required for the function of the Salmonella 
protein in vivo [135, 259]. This shows a unique ability of a pathogen to exploit the host cell 
by manipulating the farnesylation machinery for modification of bacterial effector proteins. 
Further investigation into effectors that are translocated from attached extracellular bacteria 
could prove valuable to determine host cellular processes that are manipulated from attached 
bacteria that could benefit the infection.   
 While there are seven L. pneumophila effectors harboring the eukaryotic CaaX motif, 
there are only five F-box proteins in L. pneumophila (Lpg2525, LicA, PpgA, LegU1 and 
LegAU13 which is the AnkB homologue in the Philadelphia L. pneumophila strain) [131, 
228]. Three of these are bona fide F-box proteins (LicA,AnkB LegU1) that interact with the 
Skp1 component of the SCF1 E3 ubiquitin ligase complex, while the predicted F-box motifs 
identified in PpgA and Lpg2525 may not be functional in the eukaryotic hosts, as they do not 
bind Skp1 [228]. Therefore, in addition to AnkB, L. pneumophila has acquired 3 additional 
functional F-box proteins that likely ubiquitinate other host proteins in a proteasomal 
dependent manner similar to AnkB [228]. The F-box protein LegU1 has been shown to 
ubiquitinate the eukaryotic protein BAT3 [228], but the effect of this ubiquitination is not 
known. Importantly, unlike AnkB in the AA100/130b strain and the Paris which is required 
for LCV polyubiquitination and intracellular replication, the homologue to AnkB in the 
Philadelphia strain LegAU13 does not cause polyubiquitination of the LCV and is not 
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required for intracellular replication [131, 228, 239, 260]. Therefore, the genetic diversity 
within ankB demonstrates the capability of L. pneumophila to survive intracellularly through 
several different mechanisms not shared among the strains. Determining the targets of AnkB 
in each of the strains could provide a solution for the phenotypic differences observed among 
the L. pneumophila strains. It is possible that the substrates of AnkB are different among the 
strains and specific substrates recognized by AnkB in the AA100/130b strain and the Paris 
strain provide the amino acids needed to support intracellular replication. L. pneumophila is 
auxotrophic for seven amino acids, indicating the preference and importance of obtaining 
host amino acids during the infection. In the Philadelphia strain of L. pneumophila the LCV 
is polyubiquitinated by the effector SidC, however the consequence of this polyubiquitination 
is not known [261]. 
 Similar to the farnesylation enzymes, the Skp1, Cul1 and Rbx1 components of the 
SCF1 E3 ubiquitin ligase complex are cytosolic enzymes in mammalian cells [218]. The 
recruitment of the SCF1 complex to the plasma membrane beneath extracellular bacteria 
most likely results from the strong interaction the F-box proteins with the cytosolic Skp1 
enzyme. This highlights the first example of the host cell ubiquitination machinery being 
recruited to the site of attachment of extracellular bacteria to provide a function critical to the 
subsequent intracellular survival of L. pneumophila.  
 Taken together, the recruitment of the eukaryotic farnesylation and ubiquitination 
machineries to the point of extracellular bacterial attachment show a unique ability of an 
intracellular pathogen to manipulate host cell machineries to provide altered sub-cellular 
localization of bacterial effector proteins. The strategies are utilized by L. pneumophila to 
create a surplus of amino acids and prevent a starvation response. Further research will 
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probably lend evidence to other intracellular pathogens to trigger a surplus of host cell 























Results Section 2. The complete and ubiquitinated proteome of the Legionella-containing 
vacuole within human macrophages. 
 
Purification of the LCV from human macrophages 
Due to the requirement of lysine48-linked polyubiquitination of the LCV in the 
AA100/130b L. pneumophila strain, we sought to determine the identity of the 
ubiquitinated proteins localized to the LCV. Some of these ubiquitinated proteins 
localized to the WT strain LCV are possible targets of the F-box effector protein AnkB 
which acts as the scaffold protein to cause lysine48-linked polyubiquitination of its 
ankyrin domain substrates on the LCV. To determine the identity of the ubiquitinated 
proteome, LCV’s must be isolated from the WT strain and ankB mutant strain, therefore 
we sought to determine the identity of all host proteins on the LCV in addition to the 
ubiquitinated proteome. In addition, this work will provide the first proteome of the LCV 
isolated from human macrophages, the only known mammalian host.  
 U937 human macrophages were infected with L. pneumophila WT strain 
AA100/130b or its isogenic ankB mutant strain. The ankB mutant strain evades 
lysosomal fusion and is localized within an ER-derived LCV, similar to the WT strain 
[131]. However, the ankB mutant strain fails to replicate within human macrophages and 
amoeba due to the levels of cellular amino acids being below the threshold needed as the 
major source of carbon and energy to support intra-vacuolar proliferation of L. 
pneumophila [86, 250, 262].  The U937 human macrophage cell line is widely used in 
studies on Legionella-human macrophage interaction and was used in this study instead 
of primary human monocytes due to the need of a large number of cells to isolate LCVs, 
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since only ~20% of the cells become infected.  Following a 4h infection of 6X108 U937 
macrophages, LCVs were purified according to previously reported protocols with minor 
modifications [147, 263]. Cells were lysed through dounce homogenization and the post-
nuclear supernatant (PNS) was used to isolate LCVs through density ultracentrifugation 
on a discontinuous sucrose gradient which resulted in purified LCVs at the 55-65% 
interface (Fig. 8A). To ensure vacuole integrity following purification, isolated LCVs 
were evaluated using confocal microscopy after differential membrane permeabilization 
as well as vacuole marker staining to ensure the LCV membranes were intact (Fig. 8 B-
C). Vacuoles were labeled with a polyclonal anti-Legionella antibody prior to vacuolar 
permeabilization, which resulted in ~20% of bacteria being labeled (data not shown), 
while 100% of bacteria were labeled after vacuolar membrane permeabilization, 
indicating the LCV membrane is intact on ~80% of the isolated LCVs (Fig. 8B). We next 
evaluated the presence of polyubiquitinated proteins, which showed that ~70% of isolated 
LCVs were decorated with polyubiquitinated proteins (Fig. 8C). Isolated LCVs were 
solubilized in 1% Triton X-100 and the eukaryotic proteins associated with the LCV were 
identified by high throughput Liquid Chromatography coupled with tandem Mass 
Spectrometry (LC-MS). The MS was loaded with 2µg of protein for each LCV sample. 
The proteome was obtained from analyses of two LCV preparations of the WT strain and 
the ankB mutant, and only the proteins that were reproducible in both preparations were 
included in our analyses.  A positive protein identification for the proteome was based on 
at least two unique peptides.  Although numerous proteins were identified, it is likely that 




Fig. 8. LCV purification using a discontinuous sucrose gradient. U937 macrophages 
were infected with WT L. pneumophila or the isogenic ankB strain at an MOI of 50 for 
30 minutes washed and the infection proceeded for 4 hours. Cells were lysed through 
dounce homogenization and the post-nuclear supernatant was used to isolate LCVs 
through density ultracentrifugation on a discontinuous sucrose gradient. A) Diagram of 
the sucrose gradient showing the isolated LCVs at 55-65% interface and B) confocal 
microscopy of isolated LCVs labeled with mouse anti-L. pneumophila following vacuole 
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membrane permeabilization. C) Confocal microscopy of isolated LCVs labeled with 




The Total LCV Proteome  
The proteome of WT strain AA100/130b LCV contained 1,193 eukaryotic 
proteins, while the LCV of the ankB mutant strain contained 1,546 eukaryotic proteins 
(Supp Tables 1 and 2 that are found in Bruckert et al. Journal of Proteome Research) 
[264]. We profiled the proteins according to various cellular functions, including 
transcription/translation, vesicle trafficking, immune response, ribosomal proteins, 
ubiquitination, proteasome machinery components, signaling, cytoskeleton arrangement, 
and metabolism (Fig. 9 and 10). Using these categories we identified the largest 
proportion of WT strain LCV proteins to be involved in metabolism (21%) while 
cytoskeleton arrangement (12%), signaling (12%) and transcription/translation (11%) 
were highly represented (Fig. 9). Proteins involved in immune response (8%), ribosome 
machinery (6%), vesicle trafficking (6%) and ubiquitin-dependent proteolysis (6%) were 
significantly (p value ≤ 0.05) represented among the WT strain LCV proteome (Fig. 9). 
Despite the presence of additional proteins on the ankB mutant LCV, the overall 
distribution of the proteins based on cellular function were very similar to the WT strain 
LCV proteome (Fig. 9 and 10). The large numbers of shared proteins on isolated LCVs of 
WT strain and the ankB mutant were consistent with the findings that the ankB mutant 
strain is localized in an ER-derived LCV that evades lysosomal fusion [131] but lacks 
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sufficient levels of amino acids for intra-vacuolar proliferation [86]. The ankB mutant 
LCV contained 80% of the proteins on the WT strain LCV with an additional 354 
proteins primarily involved in regulation and initiation of translation, transcription, 
apoptosis, and immune response signaling. It is likely that degradation of lysine48-linked 
polyubiquitinated proteins on the WT strain LCV renders them undetectable by 
proteomic analysis. The degradation of lysine48-linked polyubiquitinated proteins on the 
WT strain LCV also alters the relative abundance of identifiable proteins in the proteome 
of the two strains. However, it is unknown if any of the additional 354 proteins on the 
ankB mutant strain LCV are the targets of AnkB.  
Proteome data of the WT strain LCV regarding metabolism identified proteins 
involved in neutral amino acid transport (SLC1A5, SLC38A2, SLC3A2), cationic amino 
acid transport (SLC7A1) and monocarboxylate transport (SLC16A1, SLC16A3) as well 
as a variety of ATPases involved in calcium, sodium and potassium transport. A large 
proportion of metabolism related proteins are involved in carbohydrate metabolism, 
especially glycolysis or glucose transport (7%), while 5% are involved in lipid 
metabolism. Both the ankB mutant and WT strain LCV proteomes harbor 
phosphatidylinositol phosphatases (INPP5D, INPPL1), kinases (PI4KA), 
phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating proteins (ARAP1, 
ASAP1) and guanine exchange factors (SWAP70, PREX1, DEF6) (Supp Tables 1 and 2 
that are found in Bruckert et al. Journal of Proteome Research) [264]. There are also 
proteins that bind to membranes or vesicles enriched in phosphatidylinositol that function 
in early endosomal trafficking (CLINT1, RUFY1) and receptor-mediated endocytosis 
(EPN1). Consistent with the findings that the LCV of the WT strain and the ankB mutant 
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strain is RER-derived, the proteome data revealed 70-80 (6%) 40S and 60S ribosomal 
associated proteins present on WT and ankB mutant LCVs (Fig. 2 and 3). Our data 
identified 6-7% of the WT and ankB mutant LCV proteomes play a role in vesicular 
trafficking, which included 8 small Rab GTPases (Rab1, Rab2, Rab5, Rab6, Rab7, 
Rab10, Rab11 , Rab14) as well as 4 sorting nexins and multiple ADP ribosylation factors 
involved in endocytic recycling, vesicle transport and vesicle budding. The ankB mutant 
LCV had 4 additional Rab GTPases (Rab8, Rab13, Rab27 and Rab35) (Supp Tables 1 
and 2 that are found in Bruckert et al. Journal of Proteome Research) [264]. The high 
similarity in ribosomal and vesicular trafficking proteins in WT and ankB mutant LCV 
proteomes is very consistent with the findings on biogenesis of the ankB mutant LCV is 
very similar to the WT strain [131].  
Proteins involved in apoptosis and immune responses, which comprise 8% of the 
WT strain LCV proteome, were also identified. These include multiple major 
histocompatibility complex proteins, ligands and receptors involved in T cell adhesion 
(intercellular adhesion molecule 1, 3) and signaling (leukocyte-associated 
immunoglobulin-like receptor 1, HCLS1 binding protein 3), promoters of  cell apoptosis 
(BCL2-associated athanogene 6, caspase recruitment domain family member 6), 
inhibitors of apoptosis (defender against cell death 1, FAM129B) and TNF-α regulators 
and proteins, which promote LPS-induced TNF-α production (thymocyte selection 
associated family member 2). The proteome of the ankB mutant LCV contained 84 of the 
92 immune response proteins on the WT strain LCV with an additional 42 proteins. 
These include 7 cluster of differentiation molecules (CD109, CD47, CD58, CD63, CD82, 
CD83, CD84), 2 BCL2 associated proteins (BAG3, BAX) and 2 negative regulators of 
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apoptosis (TNFAIP8 and AVEN) (Supp Tables 1 and 2 that are found in Bruckert et al. 
Journal of Proteome Research) [264].  
Proteins involved in cellular signaling pathways on the WT strain and the ankB 
mutant LCV include tyrosine-protein kinases that play a role in the response to 
environmental stress and cytokines such as TNF-α (MAP4), regulation of cell growth, 
differentiation, migration and the immune response (CSK), cytoskeleton remodeling in 
response to extracellular stimuli, cell motility and receptor endocytosis (ABL2, ARAP1). 
Additional signaling proteins included Rho GTPase activating proteins (ARHGAP1, 
ARHGAP17, ARHGAP18), Rab GTPase activating proteins (TBC1D10B, TBC1D15, 
TBC1D5) and guanine nucleotide-binding proteins (G proteins).  
The WT strain and ankB mutant LCV proteomes contained proteins involved in 
cytoskeletal membrane integrity and organization (actin, coronin) and proteins that 
regulate actin and microtubule polymerization (ARP2/3 complex, KANK1, LASP1,). 
Interestingly, molecular chaperones that play a role in the folding of actin and tubulin 
(CCT2-CCT8) were present on the LCV, possibly indicating following initial LCV 
formation various cytoskeleton proteins are constantly recruited to the LCV membrane 
[265].  
 
Validation of many of the proteins detected in the proteome of the LCV in our 
analyses comes from published studies that showed that at least 17 of the proteins 
identified in our proteome have been already shown to be localized to the LCV using 
different strategies, such as confocal microscopy [74, 79, 135, 147, 237]. The WT strain 
and ankB mutant LCV contain a significant portion (6%) of proteins involved in 
ubiquitination and proteasomal degradation (Fig. 9 and 10). In agreement with findings of 
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colocalization of farnesyltransferaseα [135], SKP1 [241] and p97 [237] with the LCV by 
confocal microscopy, our proteome data identified the SKP1 component of the SCF E3 
ubiquitin ligase complex and the ATPase p97 on the LCV. In addition, both proteomes 
contained RAD23A and RAD23B which serve as multiubiquitin chain receptors that bind 
to the 26S proteasome and delivers K48-linked polyubiquitinated proteins for proteasomal 
degradation. Four E2 ubiquitin conjugating enzymes and eight E3 ubiquitin ligases were 
identified on the WT strain LCV (Table 1). The E3 ubiquitin ligases identified on the WT 
strain LCV regulate apoptosis, NF-κβ activation and IFN-β production [266, 267]; while 
the E2 ubiquitin conjugation enzymes catalyze the synthesis of K48 and K63-linked 
polyubiquitin chains [260, 268] (Table 1). The eight ubiquitin specific peptidases on the 
WT strain LCV can act as deubiquitinases (VCPIP1(p97), USP14, USP15, USP9X), that 
are able to remove ubiquitin moieties from polyubiquitin chains, which prevents 
proteasomal degradation, or are involved in lysine48-linked polyubiquitination 
disassembly (USP5) (Table 1). The ankB mutant LCV contained nine E3 ubiquitin 
ligases of which three were found on the WT strain LCV (Table 2). The E3 ubiquitin 
ligases on the ankB mutant LCV are involved in regulation of DNA, p53 activation and 
mTORC1 signaling pathway [269, 270]. The ankB mutant LCV contained four additional 
ubiquitin-conjugating enzymes including two atypical ubiquitin conjugating enzymes 
(UBE2H, UBE2O) and UBE2M, which catalyze the attachment of the ubiquitin like 





Fig. 9. Functional classification of eukaryotic proteins localized to the WT strain 
LCV. The 1193 eukaryotic proteins localized to the WT strain LCV identified by High 
Throughput LC/MS were grouped according to their cellular function according to the 






Fig. 10. Functional classification of eukaryotic proteins localized to the ankB mutant 
strain LCV. The 1546 localized to the ankB mutant LCV identified by High Throughput 
LC/MS were grouped according to their cellular function according to the UniProt and 
GeneCards database sets.  
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MetaCore Analysis of the total LCV proteome 
Bioinformatic analysis of the LCV proteome was performed using MetaCore 
(Thomson Reuters) [248, 249]. MetaCore software determined the most significant 
relationships among pathway maps, process networks, GO processes and metabolomic 
pathways from eukaryotic proteins localized to the LCV. The top pathway maps 
identified in WT and ankB mutant LCV proteomes include regulation of the actin 
cytoskeleton by Rho GTPases, the role of PKA in cytoskeleton remodeling and integrin 
mediated cell adhesion. Signaling pathways including G-protein signaling - RhoA 
regulation pathway and G protein-α 12 signaling pathways were also identified in the 
proteome pathway enrichment analysis. The generated pathway maps correlate with the 
proteome data that reveal a large proportion (12%) of LCV proteins are involved in 
cytoskeletal formation of the LCV.  
Bioinformatic analysis of metabolic networks in the WT strain LCV proteome 
revealed the phosphatidylinositol-4,5-diphosphate pathway and phosphatidylinositol-
3,4,5-triphosphate pathway as two of the top five (Fig. 11). These data reflect the 
aforementioned results of a wide array of phosphatidylinositol-dependent proteins in the 
WT strain and the ankB mutant LCV proteomes. This is also consistent with findings that 
have shown the LCV is decorated with phospatidylinositol-4 phosphate (PI(4)P) to which 
multiple effector proteins (SidC, SidM, SdcA, RidL) bind on the LCV membrane [74, 
80]. Carbohydrate metabolism (glycolysis, gluconeogenesis and glucose transport) was 
the third most abundant metabolomic network identified; while valine, tryptophan and 
methionine synthesis and transport were identified in the top eight metabolic pathways 
represented in the LCV proteome (Fig. 11). Performing the MetaCore analysis on the 
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ankB mutant strain LCV proteome gave similar results to the WT strain LCV, such as the 
phosphatidylinositol-4,5-diphosphate pathway and phosphatidylinositol-3,4,5-
triphosphate pathway.  
When proteins found only on the WT strain LCV but not the ankB mutant LCV 
were analyzed through MetaCore, many of the pathways were consistent with the total 
WT strain LCV proteome, such as phosphatidylinositol-4,5-diphosphate pathway. The 
finding that the ankB mutant proteome contained 80% of the proteins present in the WT 
strain LCV proteome is consistent with the MetaCore analysis of very similar pathways 
in both of the proteomes. Interestingly, Ubiquitin-proteasomal proteolysis was identified 
as the second most abundant process network involved in WT strain LCV specific 
proteins despite the findings that the ankB mutant LCV proteome contains a majority of 
the proteins found in the WT strain LCV proteome. These results are consistent with the 
requirement of polyubiquitination of the WT strain LCV for intracellular replication. 
Another explanation could be due to the WT strain LCV containing 350 less proteins than 
the ankB mutant strain, therefore the increase in lysine48-linked polyubiquitinated 
proteins, proteasomal subunit proteins or the SCF1 E3 ubiquitin ligase components 
recruited to the WT LCV would be more significant due to the decreased number of total 









Fig. 11. MetaCore enrichment analysis of metabolic networks in the WT Strain 
LCV proteome. The complete WT strain LCV proteome was analyzed through 
MetaCore software, using the enrichment analysis function, to identify the most 





The ubiquitinated proteome of the LCV 
 To identify ubiquitinated proteins on the WT and ankB mutant LCV, the 
solubilzed LCV proteins were immunoprecipitated with anti-ubiquitin antibodies and 
identified by LC/MS. We identified 24 ubiquitinated proteins on the WT strain LCV such 
as Annexin A2, Plasminogen activator inhibitor, Rab5 GDP/GTP exchange factor and 
Transitional endoplasmic reticulum ATPase (p97) (Table 2). The polyubiquitinated 
proteins identified on the LCV were K6, K11, K27 and K48-linked as evident from the 
findings that ubiquitin was ubiquitinated on the 4 lysine residues K6, K11, K27 and K48. 
Interestingly, 6 (25%) of the ubiquitinated proteins on the WT strain LCV play a role in 
the immune response such as interleukin-1 receptor-associated kinase 1 and Interferon 
regulatory factor 7, which play a key role in the signaling and regulation of the immune 
system against pathogens. Furthermore, we identified 2 amino acid transporters (SLC3A2 
and SLC1A4) and a sodium bicarbonate transporter (SLC4A7) to be ubiquitinated on the 
WT strain LCV. We analyzed these proteins through the Mammalian Ubiquitination Site 
Database [271] which contains a comprehensive list of all ubiquitination sites on 
mammalian proteins. The search revealed that 17 of the identified ubiquitinated proteins 
have been shown to be ubiquitinated on the same lysine residues as identified in our 
LC/MS analyses. However, three of the ubiquitinated proteins identified (Plasminogen 
activator inhibitor 2, Mast cell-expressed membrane protein 1, Isoform 13 of Sodium 
bicarbonate cotransporter 3) were not in the database, while four (Vimentin, Target of 
Myb protein 1, Receptor-type tyrosine-protein phosphatase C, Transient receptor 
potential cation channel subfamily V member 2) were in the database but have been 
previously shown to be ubiquitinated on other lysine residues than the ones we identified 
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in our analysis. The ankB mutant LCV contained 29 ubiquitinated proteins primarily 
involved in signaling (Integrin beta-1, beta-2 and alpha-5, Rho GDP-dissociation 
inhibitor 2) and ubiquitination (Cullin-5, the E3 ubiquitin ligase LAPTM5 and the E2 
Ubiquitin-conjugating enzyme E2N) (Table 3). The ankB mutant LCV had multiple 
ubiquitinated transporters, including the monocarboxylate transporter (SLC16A3), the 
glucose transporter (SLC2A3), and neutral amino acid transporters (SLC3A2, SLC1A5) 
as well as 2 ATPases (ATP2B4 and ATP13A3) (Table 3).  
While the WT strain and ankB mutant strain LCV had some common 
ubiquitinated proteins (p97, SLC3A2, tubulin), there was a significant difference in the 
ubiquitinated proteome among the two strains, as can be seen by the superscript alpha 
designation in the WT strain ubiquitinated proteome table (Table 3). The major 
differences in the ubiquitinated host proteins between the two strains could be attributed 
to the proteasomal degradation of K48-linked polyubiquitinated proteins on the WT strain 
LCV, and the dynamic changing nature of LCV. The ankB mutant LCV had multiple 
ubiquitinated proteins involved in intracellular trafficking (Rab1A, Rab14) and two 
GTPases (Rac1, RhoG), while the WT strain only contained one ubiquitinated protein 
involved in intracellular trafficking (Rab5 GDP/GTP exchange factor) (Table 3-4). 
Furthermore, the ubiquitinated proteins on the WT strain LCV that were excluded from 
the ankB mutant strain LCV can be utilized to determine the AnkB substrates, that are 




















Discussion Section 2 
While the LCV proteome has been characterized from the mouse macrophage cell 
line RAW264.7 and D. discoedium [73, 74], there has not been a complete LCV proteome 
analysis from human macrophages. While RAW264.7 mouse macrophages support 
intracellular replication, they originate from the BALB/C mouse, which are non-permissive 
to L. pneumophila infection [76, 272]. Therefore, generation of the LCV proteome from 
human macrophages is a valuable resource for studies focusing on LCV biogenesis within 
human cells. Due to the requirement of K48-linked polyubiquitinated proteins on the LCV, 
determining the ubiquitinated proteome of the LCV will show host proteins modified during 
infection that could be crucial for intracellular replication. Utilizing the ankB mutant strain as 
a control for generating the proteome is valid due to the similarity in LCV biogenesis and 
trafficking to the WT strain. In addition, utilizing the ankB mutant strain allowed the 
identification of WT strain-specific ubiquitinated proteins, some of which could be ankB 
substrates that are required for intracellular replication.  
The WT strain LCV proteome contained a unique assortment of E2 ubiquitin-
conjugation enzymes and E3 ubiquitin ligases. Out of the 4 E2 ubiquitin-conjugation 
enzymes (UBE2K, UBE2N, UBE2L3, UBEV1) only UBE2K and UBE2L3 synthesize K48-
linked polyubiquitinated chains [268]. The WT strain LCV proteome confirmed previous 
results of the SKP1 component of the SCF1 E3 ubiquitin ligase complex and VCP (p97) 
localized to the LCV [237, 241]. Interestingly, SKP1 and VCP are needed for intracellular 
replication, due to SKP1 ubiquitinating AnkB substrates and VCP removing the K48-linked 
polyubiquitinated proteins from the LCV for proteasomal degradation [237, 238]. Therefore, 
UBE2K and UBE2L3 could be the missing piece of LCV polyubiquitination, and function to 
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polymerize the K48-linked polyubiquitination of the AnkB substrates. Interestingly, we 
identified multiple ubiquitin specific peptidases on the LCV which function in a regulatory 
role to prevent proteasomal degradation of the ubiquitinated protein [204]. Ubiquitin 
peptidases remove conjugated ubiquitin from linkages other than K48, which complicates the 
identification of LCV associated ubiquitinated proteins. These peptidases could also alter the 
state of LCV ubiquitination, thereby influencing protein turnover in the infected cell. The 
function of the E3 ubiquitin ligases on the LCV could prove valuable to determine if they are 
modifying bacterial proteins or if they are recruited to the LCV by effector proteins in a 
manner to direct ubiquitination of specific target proteins. The E3 ubiquitin ligase Huwe1 
found in the WT strain LCV proteome regulates apoptosis through ubiquitination of Mcl-1 
[267], while the E3 ubiquitin ligase Birc6 found on the WT strain and ankB mutant strain 
LCV ubiquitinates apoptotic proteins in a proteasomal dependent manner [266]. Other anti-
apoptotic proteins on the LCV such as defender against cell death could play an important 
role in preventing host cell apoptosis and therefore limiting bacterial replication. The pro-
apoptotic proteins on the LCV, such as apoptosis-inducing factor, show a unique balance 
between pro and anti-apoptotic events during L. pneumophila infection. This balance is of  
importance due to L. pneumophila activating caspase 3, which does not lead to apoptosis, as 
well as determining why permissive macrophages are resistant to apoptotic stimuli during 
infection [62, 63, 67, 68].  
Due to the essential recruitment of polyubiquitinated proteins to the LCV in                 
L. pneumophila strain AA100/130b and the Paris strain [238, 239], we sought to determine 
the identity of these ubiquitinated proteins to decipher which host proteins were manipulated 
during infection of human macrophages. Six of the 24 ubiquitinated proteins found on the 
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WT strain LCV are involved in the immune response. These ubiquitinated immune response 
proteins include interferon regulatory factor 7 (IRF7) and interleukin-1 receptor-associated 
kinase 1 (IRAK1). IRF7 is a key transcriptional regulator of type I interferon (IFN)-
dependent immune responses, which is critical for clearance of many DNA and RNA viruses 
[273]. Interestingly, the E3 ubiquitin ligase Trim21 ubiquitinates IRF7 in a proteasomal 
degradation manner [274]. Furthermore, IRF7 ubiquitination could also contribute to the 
inhibition of apoptosis during L. pneumophila infection. IRAK1 plays a role in mediating 
pro-apoptotic signaling in response to bacterial LPS [275]. Therefore, similar to IRF7, the 
ubiquitination of IRAK1 could play a significant role in intracellular immune response 
during infection [273]. The ankB mutant strain LCV ubiquitinated proteome contained 
Rab1A and Rab14. While Rab1A plays a crucial role in LCV remodeling and trafficking 
[78], this ubiquitination could explain an additional regulatory mechanism for LCV 
biogenesis and endo-lysosomal evasion. Additionally, the ankB mutant strain ubiquitinated 
proteome contained multiple proteins involved in ubiquitination and amino acid transport, 
such as the ubiquitin-conjugating enzyme E2N, cullin5, SLC1A5 and SLC3A2. The WT 
strain ubiquitinated proteome also contained the amino acid transporter SLC3A2 as well as 
the amino acid transporter SLC1A4. The ubiquitination of these amino acid transporters 
could alter their subcellular localization to enable their localization to the LCV. This could 
explain how intra-vacuolar L. pneumophila is able to transport amino acids across the LCV 
lumen to provide the carbon and energy essential for intracellular replication. The 
ubiquitinated proteome of the WT and ankB mutant strain LCV each contained K6, K11, K27 
and K48-linked polyubiquitinated proteins. Further studies are needed to determine the chain 
linkages of the ubiquitinated proteins as well as characterizing the importance of the non-
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K48-linked polyubiquitinated proteins. While it is known the K48-linked polyubiquitinated 
proteins are essential for intracellular replication [86], the other ubiquitinated proteins could 
prove valuable to decipher vacuole remodeling and biogenesis.   
L. pneumophila must acquire nutrients primarily in the form of amino acids from the 
host during infection [86, 262]. It is not known how amino acids are transported into the 
LCV lumen, however it is known that the eukaryotic amino acid transporter SLC1A5 is 
required for intracellular replication within human macrophages [85]. In the WT strain and 
the ankB mutant strain LCV proteomes we identified five amino acid transporters (SLC1A4, 
SLC1A5, SLC3A2, SLC7A5, SLC38A2). While SLC1A5 is required for L. pneumophila 
infection of human macrophages [85], there could be multiple amino acid transporters on the 
LCV that function together to bring a variety of amino acids into the LCV. The more 
important question is what directs these amino acid transporters to the LCV and how they 
anchor into the LCV membrane. A transmembrane L. pneumophila effector could bind these 
transporters and stabilize them on the LCV membrane allowing import of amino acids, or the 
transporters could fuse with the LCV by recruitment of ER vesicles. We currently favor the 
second possibility, since the SLC transporters are transmembrane proteins. Due to the wide 
array of protozoan host L. pneumophila infects, having the ability to localize multiple amino 
acid transporters to the LCV would be a beneficial solution to nutrient acquisition in various 
host.  
The LCV proteome also contained two monocarboxylate transporters SLC16A1 and 
SLC16A3 that have the ability to transport pyruvate across the LCV membrane [276]. While 
amino acids are the main source of nutrients, the ankB mutant is restored for intracellular 
replication in human macrophages and amoeba when pyruvate is added to the culture 
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medium [86]. Therefore, incorporation of these monocarboxylate transporters into the LCV 
membrane could provide a dual strategy for L. pneumophila acquisition of sources other than 
amino acids, such as pyruvate. L. pneumophila has been shown to use glucose as an 
intracellular energy source [92], the glucose transporters identified in the LCV proteomes 
(SLC2A1, SLC2A3, SLC2A13) could allow another, yet minor, source of carbon and energy 
to support intracellular replication. With our knowledge of L. pneumophila nutrient 
acquisition not well understood, this proteome analysis in human macrophages will be a 
tremendous resource to enable studies into more specific transporters not previously known 
to be localized to the LCV. While SLC1A5 is required for infection it is more likely that 
combinations of amino acid, monocarboxylate and glucose transporters are recruited to the 
LCV to provide intra-vacuolar L. pneumophila with a diverse portfolio of sources of carbon 
























Results Section 3. Lysine11-linked polyubiquitination of the AnkB  
 
effector of Legionella pneumophila 
 
Ubiquitination of the L. pneumophila translocated effector AnkB  
It has been shown that eukaryotic F-box proteins undergo autoubiquitination 
through the direct interaction with the SCF1 E3 ubiquitin ligase complex [221, 226]. 
However, to our knowledge ubiquitination of F-box proteins independent of their F-box 
domain has not been investigated. To further investigate the function of F-box proteins 
we choose to further characterize the eukaryotic F-box L. pneumophila effector protein 
AnkB.  
To determine whether AnkB undergoes ubiquitination within eukaryotic cells, we 
immunoprecipitated ectopically expressed Flag-tagged AnkB and analyzed by Western 
Blot. In addition to the native AnkB band at ~23kDa there were two distinct bands at 
~37kDa and ~75kDa, as well as a smear of high molecular weight proteins recognized by 
anti-Flag antibodies (Fig. 12). No bands were detected in the lysate of cells transfected 
with the vector alone, which suggested that the distinct bands at ~37kDa and ~75kDa 
may correspond to the potential addition of two and six ubiquitin monomers to AnkB 
since 1 ubiquitin monomer is 8.5 kDa (Fig. 12). Re-probing that membrane with anti-
ubiquitin antibodies on AnkB showed the presence of higher molecular mass species that 
were ubiquitinated (Fig. 1). To ensure that ubiquitination of AnkB was not only limited to 
the L. pneumophila strain AA100/130b we also analyzed AnkB from the L. pneumophila 
Paris strain [239], which lacks the C-terminal CaaX motif [135]. We performed 
immunoprecipitation of Flag-tagged AnkB Paris and probed the membrane with anti-Flag 
antibodies. Similar to the AA100/130b-derived AnkB, the Paris strain AnkB showed 
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distinct bands and a high molecular weight smear that suggested the ubiquitination of 
AnkB (Fig. 12).  
AnkB is a bona fide F-box protein [238, 239] and its F-box domain interacts 
directly with the SKP1 component of the host SCF1 E3 ubiquitin ligase complex on the 
LCV [238, 239]. To determine if the F-box domain of AnkB was required for its 
ubiquitination, we transfected HEK293T cells with an AnkB variant lacking the F-box 
domain and immunoprecipitated the protein. Western blot analysis showed the deletion of 
the F-box domain of AnkB did not have an impact on its ubiquitination (Fig. 13). To 
ensure that deletion of the F-box domain did not have an impact on the structure of 
AnkB, we utilized an AnkB substitution mutant (AnkB9L10P/AA) within the F-box 
domain that does not bind to SKP1 [238]. Following immunoprecipitation of 
AnkB9L10P/AA, the western blot showed that (AnkB9L10P/AA) was ubiquitinated similar 
to the native AnkB (Fig. 13). Taken together these results highly suggest that AnkB is 
ubiquitinated and its ubiquitination is independent of the interaction of its F-box domain 
with the host SCF1 E3 ubiquitin ligase complex, which indicates that AnkB is modified 




Fig. 12. Ubiquitination of ectopically expressed L. pneumophila strain AA100/130b 
and the Paris strain AnkB. HEK293T cells were transfected with 3X-Flag tagged AnkB 
from L. pneumophila strain AA100/130b or the Paris strain. Cell lysates were purified 









Fig. 13. Ubiquitination of AnkB variants lacking the F-box domain. 
HEK293T cells were transfected with the AnkB variants 3XFlag-tagged AnkB9L10P or 
3XFlag-tagged AnkBΔFbox. Cell lysates were purified with anti-Flag agarose and 




Interaction of AnkB with the E3 ubiquitin ligase Trim21  
 The ubiquitination of the AnkB variant lacking the F-box domain, as well as the 
AnkB9L10P/AA substitution variant allowed us to exclude a role for the SCF1 E3 
ubiquitin ligase in AnkB ubiquitination. We came to this conclusion since AnkB is 
unable to bind the SKP1 component in either of these AnkB flag-tag variants (AnkB9L10P 
and AnkBΔFbox) , therefore it is highly unlikely that the ubiquitination of AnkB is 
dependent upon the SCF1 E3 ubiquitin ligase complex. In addition the targets of AnkB 
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can not be ubiquitinated by AnkB in the absence of the F-box domain of AnkB, therefore 
the ubiquitination of the AnkB variants (AnkB9L10P and AnkBΔFbox) highly suggest 
AnkB, and not its interacting substrates, are ubiquitinated through an E3 ubiquitin ligase 
complex other than the SCF1 complex. Therefore, we sought to determine the E3 
ubiquitin ligase that interacts with AnkB. We immunoprecipitated Flag-tagged AnkB 
from HEK293T cells and performed MS analysis on the proteins that co-
immunoprecipitated with AnkB. Our mass spectrometry data showed that the RING-
finger protein Ro52 (Trim21) co-purified with AnkB. To confirm AnkB directly interacts 
with Trim21, we co-transfected HEK293T cells with Flag-tagged AnkB and HA-tagged 
Trim21. Following cell lysis, Flag-tagged AnkB was co-immunoprecipitated with anti-
Flag antibody and the immunoprecipitate was immunoblotted with anti-HA tag antibody. 
A ~52 kDa band, the correct molecular mass for Trim21, co-immunoprecipitated with 
AnkB (Fig. 14A). When the co-immunoprecipitation was reversed through 
immunoprecipitation with anti-HA antibody and the immunoprecipitate was 
immunoblotted with anti-Flag antibodies, the correct molecular mass band corresponding 
to AnkB was detected (Fig. 14B). To determine if the Trim21-AnkB interaction was 
specific for AnkB, we utilized the L. pneumophila translocated effector protein AnkH as 
a control in the co-immunoprecipitation. The Flag-tagged AnkH was co-
immunoprecipitated with anti-Flag antibodies and the resulting immunoprecipitate was 
immunoblotted with anti-HA antibodies. Unlike AnkB, Trim21 did not co-
immunoprecipitate with AnkH (Fig.14A). This was confirmed by reversing the co-
immunoprecipitation and Western Blot, which also showed lack of interaction of Trim21 
with the AnkH control (Fig. 14B). Taken together, these results indicate AnkB 
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specifically interacts with the E3 ubiquitin ligase Trim21. This is the first example of an 





Fig. 14.AnkB directly interacts with the E3 ubiquitin ligase Trim21. (A) Flag-tagged 
AnkB or Flag-tagged AnkH were co-transfected with HA-tagged Trim21 in HEK293T 
cells. Flag-tagged AnkB or Flag-tagged AnkH were co-immunoprecipitated with anti-
Flag agarose and the resulting supernatants were immunoblotted with anti-HA antibodies 
and anti-Flag antibodies. (B) HA-tagged Trim21 was co-immunoprecipitated using anti-
HA agarose and the resulting supernatants were analyzed by immunoblotting with anti-




Ubiquitinated AnkB is not degraded by the proteasome  
When proteins are polyubiquitinated through K48-linked polymerization of 
ubiquitin are degraded by the proteasome [202]. To determine whether ubiquitination of 
AnkB led to its proteasomal degradation we utilized the proteasomal inhibitor MG132 
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and determined the stability of AnkB in the presence or absence of the protein synthesis 
inhibitor cycloheximide. To ensure the MG132 proteasome inhibitor blocked proteasomal 
degradation, treated or untreated cells were lysed and the resulting western blot 
membrane of total cell lysate was probed with anti-ubiquitin and re-probed with anti-
actin antibodies. As expected, cells treated with MG132 had a large increase in the 
amount of ubiquitinated proteins compared to untreated cells (Fig. 15A). When AnkB 
was co-immunoprecipitated from cells left untreated or treated with MG132 there was not 
a difference in the amount of purified ubiquitinated AnkB (Fig. 15B). Our data showed 
that upon proteasomal inhibition, ubiquitinated AnkB was stable over the three hour 
experiment (Fig. 15C). Therefore, ubiquitination of AnkB does not result in its 












Fig.15. Ubiquitinated AnkB is not degraded by the proteasome. (A) HEK293T cells 
were untreated or treated with 20uM MG132 for 3 hours. Cells were lysed and the 
resulting immunoblot was probed with anti-ubiquitin and anti-actin antibodies. (B) 
HEK293T cells transfected with 3X-Flag tagged AnkB were treated with 20uM MG132 
for 3 hours or left untreated. An equivalent number of cells were lysed, and Flag-tagged 
AnkB was immunoprecipitated using anti-Flag agarose, and subjected to immunoblotting 
with anti-Flag and anti-ubiquitin antibodies. (C) HEK293T cells transfected with Flag 
tagged AnkB were treated with the protein synthesis inhibitor cycloheximide. To inhibit 
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proteasomal degradation, a subset of the cells were treated with 20uM MG132 two hours 
prior to cycloheximide treatment. At the indicated time points cells were lysed and 





Polyubiquitin linkages of polyubiquitinated AnkB 
Ubiquitin contains 7 lysine residues, all of which can be utilized to polymerize 
ubiquitin on the substrate protein [202]. To determine if AnkB was polyubiquitinated 
through K48and K63-linked polyubiquitination, we utilized antibodies specific for K48-and 
K63-linked polyubiquitinated proteins. These are the most studied forms of 
polyubiquitination, therefore there are commercial antibodies available. The 
immunoprecipitated AnkB did not bind antibodies specific for K48 and K63-linked 
polyubiquitinated proteins compared to total cell lysate control (Fig. 16). When the 
membrane was stripped and re-probed with anti-Flag antibodies, ubiquitinated AnkB was 
detectable (Fig. 16). Taken together, these results highly suggest that AnkB is 
polyubiquitinated through lysine linkages other than K48 or K63. If AnkB was 
polyubiquitinated through K48 or K63 we would expect to see a similar high molecular 
weight smear that was observed with the anti-ubiquitin antibodies (15B). 
Since AnkB is most likely not modified through K48 or K63-linked 
polyubiquitination we sought to determine the chain linkage of the ubiquitin polymers of 
ubiquitinated AnkB by mass spectrometry. Depending on the lysine residue within 
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ubiquitin that contains the ubiquitin-ubiquitin linkage, a characteristic mass shift increase 
of 114 Da (di-glycine) is observed by mass spectrometry [242]. The Flag-tagged AnkB 
was ectopically expressed in HEK293T cells and immunoprecipitated using anti-Flag 
antibody. Immunoprecipitated proteins were resolved by SDS-PAGE and visualized by 
Coomassie blue staining (Fig. 17). Of the several bands corresponding to AnkB with a 
different number of ubiquitin moieties, the most prominent band at ~75kDa (AnkB +6 
ubiquitin moieties) was analyzed by mass spectrometry to determine the modified lysine 
residues within AnkB and ubiquitin. Mass spectrometry analysis and the resulting spectra 
detected ubiquitination of AnkB on K67 in the peptide (63-75), that was generated 
following trypsin cleavage of the ~75kDa band (Fig. 18A). Greater than 90% of the b and  
y ions with +1, +2 and +3 charges were detected, which provided clear evidence for the 
ubiquitination of AnkB on K67 (Fig. 18A and B). When analyzing other bands from the 
Coomassie stained gel by mass spectrometry we did not observe ubiquitination of AnkB, 
however, many of the lysine residues within AnkB were not even observed following 
protein digestion. Within the same ~75kDa band, ubiquitin was ubiquitinated on K11 in 
the peptide (7-27) (Fig. 19). The b ions with a +1 charge and the y ions with a +2 charge 
surrounding the modified lysine residue of ubiquitin are shown and the calculation 
provided direct evidence for ubiquitination of ubiquitin on K11 (Fig. 19A and B). 
Although phosphorylation of proteins has been shown to be a signal for protein 
ubiquitination [277], we did not detect phosphorylated AnkB in the MS analysis (data not 
shown). If the phosphorylated amino acid of AnkB was detected we could possibly 
substitute the phosphorylated residue to inhibit the ubiquitination of AnkB. To inhibit 
host cell ubiquitination we generated a substitution mutant of the ubiquitinated K residue 
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in AnkB (AnkBK67R). However, following immunoprecipitation the resulting 
immunoblot analysis showed AnkB ubiquitination was not inhibited with this substitution 
(Fig. 20). As seen with many eukaryotic proteins and the SopB effector in Salmonella, 
ubiquitination can occur on multiple K residues within a protein [234, 278]. Taken 
together, AnkB is ubiquitinated on K67 through K11-linked polyubiquitination, and the 






Fig. 16. AnkB is not polyubiquitinated through K48 or K63 linkages. 
Immunoprecipitated Flag-tagged AnkB was analyzed by immunoblotting with antibodies 
specific for K48-linked polyubiquitinated proteins or antibodies specific for K63-linked 
polyubiquitinated proteins. Cell lysate was used as a control and anti-Flag antibodies 






Fig. 17. Commassie stain of immunoprecipitated AnkB.  
Flag-tagged AnkB was immunoprecipitated from transfected HEK293T cells and 











Fig. 18. AnkB is ubiquitinated on lysine 67. The band at ~74kDa (AnkB +6 ubiquitin) 
was analyzed by mass spectrometry and the resulting spectra within the ubiquitinated 
AnkB peptide (63-75) is shown with the b (blue lines) and y ions (red lines). (B) The 













Fig. 19. AnkB is polyubiquitinated through lysine11 of ubiquitin. (A) The previously 
analyzed ~74kDa ubiquitinated AnkB band was analyzed by mass spectrometry for 
ubiquitination of ubiquitin. The resulting spectrum of the modified ubiquitin peptide (7-
27) is shown along with the b (blue lines) and y ions (red lines) detected. The b ions with 
a +1 charge and y ions with a +2 charge are shown with the mass/charge ratio calculated 
to show ubiquitination on lysine 11 of ubiquitin. (B) The fragmentation pattern of the b 
and y ions with a +1 and +2 charge within the ubiquitin peptide (7-27). 
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Fig. 20. Substitution of AnkB K67 does not inhibit polyubiquitination. The 
ubiquitinated lysine residue in AnkB was substituted with an arginine (AnkBK67R) and 
transfected into HEK293T cells. Cell lysates were purified with anti-Flag agarose and 








Discussion Section 3 
Ubiquitination of eukaryotic proteins results in a myriad of biological consequences, 
such as proteasomal degradation, alteration in subcellular localization, signaling cascades and 
DNA repair [202, 209]. Intracellular bacteria have developed ingenious mechanisms to 
manipulate eukaryotic ubiquitination machinery for their own benefit [231, 235]. This 
manipulation can come from bacterial effectors that act as deubiquitinases, E3 ubiquitin 
ligases and F-box proteins that function identical to their eukaryotic counterpart [223, 231, 
261]. F-box proteins, such as AnkB, typically cause proteasomal degradation of substrate 
proteins [279]. The substrates of AnkB are polyubiquitinated through K48-linkages and are 
degraded by the proteasomes, however, these targets are unknown [86]. While it has been 
shown that F-box proteins undergo autoubiquitination, which results in their proteasomal 
degradation, modification of F-box proteins through polyubiquitin chain linkages other than 
K48 has not been shown [280]. Autoubiquitination of F-box proteins is primarily a control 
mechanism to limit constant degradation of their substrates and unwanted protein turnover. 
Therefore, ubiquitination of F-box proteins resulting in proteasome-independent functions 
would be novel. Perhaps F-box proteins are ubiquitinated by non K48-linked 
polyubiquitination to interact with a specific substrate, or it could repress the downstream 
signaling events that occur through F-box mediated protein-protein interactions. F-box 
proteins regulate a wide array of cellular functions through proteasomal degradation of their 
substrates, so it could be easily perceived that ubiquitination of the F-box protein could alter 
this regulation allowing more possibilities for their cellular function.    
Bacterial effectors have been shown to undergo ubiquitination during infection, 
however the majority are K48-linked polyubiquitin chain linkages, which lead to proteasomal 
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degradation [231, 281]. Detection of effector ubiquitination can be challenging, as a specific 
antibody to the effector is needed or a tag, such as HA is needed to perform 
immunoprecipitation. Fusing a tag to the effector can affect the translocation or alter the 
functions of the protein in vivo. Therefore, bacterial effectors could be modified through 
ubiquitination more commonly than has been shown in the literature due to the technical 
difficulties. The Salmonella effector SopB has been shown to be ubiquitinated through K63-
linked polyubiquitination, which alters the subcellular localization during infection, while 
SopE and SptP are ubiquitinated and degraded by the proteasome [234, 282]. These 
examples highlight the ability of bacterial effector proteins to be ubiquitinated by the host 
cell machinery with biochemical consequences on their location, stability, or function.                         
The Philadelphia strain of L. pneumophila contains five F-box proteins, of which two 
were shown to be ubiquitinated during ectopic expression [228]. One of these F-box proteins 
shown to be ubiquitinated was LegAU13, which is the homologue to AnkB in the 
Philadelphia strain [228]. Interestingly, LegAU13 in the Philadelphia strain is not required 
for intracellular replication in human macrophages or amoeba [228], while AnkB in the 
AA100/130b strain is required for intracellular replication [131]. Furthermore, LegAU13 in 
the Philadelphia strain of L. pneumophila does not cause polyubiquitination of the LCV, 
which is mediated by another L. pneumophila effector SidC [261]. However, the SidC 
mediated polyubiquitination of the LCV is not required for intracellular replication. It has 
been shown that LegAU13 directly interacts with Skp1 and Cul1 of the SCF E3 ubiquitin 
ligase complex, however the targets are unknown [228]. Therefore, this diversity in a single 
effector protein reveals how L. pneumophila has a multitude of mechanisms that give rise to 
intracellular replication. Unfortunately, it was not shown if LegAU13 is ubiquitinated in the 
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absence of the F-box domain, therefore it is not known if this ubiquitination is due to 
autoubiquitination in the Philadelphia strain. However, due to the ubiquitination of the Paris 
strain AnkB in a non-degradative manner, it is likely the same occurs for the Philadelphia 
strain AnkB as well. This raises an intriguing question as to how different L. pneumophila 
strains utilize the effector proteins they have acquired. While this dissertation focuses on 
AnkB, there is a multitude of effector proteins that allow L.pneumophila to avoid 
phagasome-lysosome fusion and the formation of the LCV which provides the platform for 
AnkB to function upon.  
The K11-linked polyubiquitination of AnkB introduces two novel findings to cellular 
biology. It is the first bacterial effector protein shown to be polyubiquitinated through K11 
linkages, and the first prokaryotic or eukaryotic F-box protein shown to be polyubiquitinated 
through K11 linkages. Interestingly, K11-linked polyubiquitination of AnkB does not lead to 
proteasomal degradation. Unlike other examples of K11-linked polyubiquitination, the 
stability of AnkB is not affected. Unlike other examples of K11-linked polyubiquitination that 
have primarily been seen by proteins involved in the cell cycle regulation through 
ubiquitination by the Anaphase –promoting complex E3 ubiquitin ligase, AnkB is a bacterial 
effector that lacks these properties [283, 284]. This atypical K11-linked ubiquitination of a 
bacterial effector raises the question if other effectors are modified through similar 
polyubiquitin chain linkages. We have observed the ubiquitination of AnkB on several 
different K residues through mass spectrometry, and the K residues were located in the C 
terminus and N terminus of the protein. It has been shown for bacterial effectors as well as 
eukaryotic proteins that ubiquitination can occur on multiple K residues and there is little 
specificity as to which K is modified [234, 278]. When two of the ubiquitinated K residues of 
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AnkB were substituted with arginine residues, ubiquitination of AnkB still occurred (though 
likely on other K residues). Therefore, it was not possible to determine if the ubiquitination is 
needed for the functional aspects of AnkB or for intracellular replication of L. pneumophila. 
AnkB contains 19 K residues, therefore we did not proceed with the substitution as we were 
concerned that substitution of 19 residues could lead to the protein function being 
compromised. However, if we could determine that the ubiquitination occurs in a specific 
region or domain of AnkB, this substitution procedure would be more accurate. Determining 
which eukaryotic E3 ubiquitin ligases are able to recognize bacterial proteins, and how this 
recognition can occur, should strengthen the information on effector ubiquitination. The K48-
linked polyubiquitination of effectors can be explained as being a foreign protein, therefore 
the E3 ubiquitin ligases marks the protein for proteasomal degradation. The mechanisms 
underlying polyubiquitination of effector proteins independent of proteasomal degradation is 
nonexistent. 
There is limited knowledge on ubiquitination other than K48 or K63, which 
includes (K6, K11, K27, K29, K33). Importantly, the K11-linked polyubiquitination of AnkB 
shows another mode of ubiquitination of bacterial effector proteins independent of 
proteasomal degradation. The ubiquitination of AnkB could result in a-conformational 
change, therefore causing AnkB to release the substrates of the ankyrin domains. This 
type of signaling has been seen with K29-linked polyubiquitination [285]. It does not 
appear that this ubiquitination would affect the subcellular localization of AnkB, as it is 
anchored into the LCV membrane through host-mediated farnesylation immediately 
following translocation [135, 241]. The ubiquitination of AnkB most likely occurs on the 
LCV during infection, however the timing of this is yet to be determined. Ubiquitination 
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of SopB from Salmonella does not occur until ~1 hour after infection, therefore in vivo 
ubiquitination analysis should be evaluated at multiple time points during infection [234]. 
The function of AnkB during infection is to provide an increase in free cellular amino 
acids, which is essential to support replication. Therefore the absence of proteasomal 
degradation during ectopic expression of AnkB supports the hypothesis that AnkB is 
functional throughout the infection. Further research into the mechanisms of this K11-
linked polyubiquitination will answer unknown questions regarding this mode of 
polyubiquitination. Therefore, while the function is unknown, this represents novel 
polyubiquitination of an F-box protein, and could present valuable information on the 





CONCLUSIONS AND FUTURE DIRECTIONS 
 
This project has determined the initial kinetics and mechanisms of the                       
L. pneumophila effector AnkB upon intimate contact of extracellular bacteria with the 
eukaryotic host. AnkB is the only one of seven eukaryotic-like ankyrin proteins in                       
L. pneumophila to be translocated from attached extracellular bacteria. This shows an unique 
ability for a bacterium to prioritize the translocation of certain effectors, probably the effector 
proteins that are needed for early aspects of intracellular replication. We conclude that AnkB 
is translocated from attached extracellular bacteria to generate a surplus of amino acids that 
prevents differentiation from the replicative phase to the transmissive phase and will power 
subsequent intracellular replication. This pre-programming of the nutrient sources in the host 
cell by AnkB shows a level of sophistication L. pneumophila has obtained to generate a 
favorable nutrient rich environment within human macrophages and amoeba.  
The recruitment of the farnesylation and ubiquitination machinery is dependent on the 
Dot/Icm secretion system; AnkB appears to play a critical role in this recruitment as the ankB 
mutant strain is less efficient at recruitment compared to the WT strain. While                       
L. pneumophila is the only intracellular pathogen known to recruit host cell farnesylation and 
polyubiquitination machineries to the point of extracellular bacterial attachment, 
undoubtedly, other intracellular pathogens manipulate host cellular processes during the 
initial infection process to establish a suitable niche for intracellular replication. 
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The polyubiquitinated proteins on the LCV have a wide range of cellular processes, 
including immune response and nutrient transport. L. pneumophila encodes at least 2 E3 
ubiquitin ligases, which could potentially ubiquitinate some of the immune response proteins 
included in the ubiquitinated proteome, causing their proteasomal degradation and thereby 
influencing the immune response of the cell. To determine the substrates of AnkB is an 
ongoing process that will identify specific eukaryotic proteins that are degraded by the 
proteasomes to generate a surplus of amino acids. Ankyrin domains have the ability to bind 
more than one interacting protein. Therefore it is unknown how many substrates AnkB has or 
if the substrates are proteins expressed in high abundance. The ubiquitinated proteome can be 
utilized in RNAi knockdown experiments of the identified proteins, which can help 
distinguish which ubiquitinated proteins are required for intracellular replication. The 
unknown ubiquitinated targets of AnkB are most likely in the ubiquitinated proteome of the 
WT strain and therefore we have reduced the amount of possible binding partners from the 
~250 proteins localized to WT strain LCV’s and excluded from the ankB mutant strain LCV. 
The K48-linked polyubiquitinated substrates of AnkB are degraded by the proteasomes, 
therefore another possibility is that proteins found on the ankB mutant strain LCV and 
excluded on the WT strain LCV could be the AnkB substrates. However, due to the 
published confocal microscopy data showing the cloud of polyubiquitinated proteins 
surrounding the LCV throughout infection, we favor the former possibility. The E2 ubiquitin-
conjugating enzymes and the E3 ubiquitin ligases in the complete LCV proteome can help 
decipher the complexity of the LCV ubiquitination and perhaps determine additional host cell 
ubiquitination machinery that is required for infection, which was previously shown for the 
SCF1 E3 ubiquitin ligase complex. Knockdown experiments using RNAi on the E3 ubiquitin 
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ligases and the E2 ubiquitin-conjugating enzymes can determine which are needed and 
possibly manipulated by L. pneumophila during infection. Furthermore, the identified E3 
ubiquitin ligases can polyubiquitinate L. pneumophila effectors leading to their proteasomal 
degradation, altered sub-cellular localization or function.  
To date we have not been able to inhibit the ubiquitination of AnkB by substituting 
the ubiquitinated lysine residue with an arginine residue. Therefore, we have not been able to 
determine the effect of the lysine11-linked polyubiquitination of AnkB. However, the 
polyubiquitination of AnkB does not result in its proteasomal degradation. As AnkB is the 
first F-box protein shown to be modified through lysine11-linked polyubiquitination, 
determining the mechanism could add valuable evidence into the field of 
lysine11polyubiquitination. Lysine11-linked polyubiquitination of AnkB could possible 
disrupt the binding between the ankyrin domains of AnkB and their target proteins or 
possibly cause some downstream signaling events to occur. Future studies will be to 
substitute multiple lysine residues in AnkB with arginine residues, and perform the same 
immunoprecipitation experiments to determine if lack of ubiquitination changes the function 
of AnkB. This substitution method was performed with the Salmonella effector SopB, where 
they noticed SopB was polyubiquitinated through K63 and the result was an altered sub-
cellular localization[234]. Understanding the mechanism of the lysine11-linked 
polyubiquitination will provide information on effector protein polyubiquitination, which is a 
field with only a few examples. While AnkB specifically interacts with Trim21 it has not 
been experimentally verified that Trim21 ubiquitinates AnkB. Using siRNA against Trim21 
did not abolish the ubiquitination of AnkB, therefore we could not conclude Trim21 
ubiquitinates AnkB (data not shown). However, technical issues with anti-Trim21 antibodies 
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possibly played a role in determining efficient knockdown. Therefore, future experiments 
would look into the AnkB-Trim21 interaction and determine if Trim21 is the E3 ubiquitin 
ligase responsible for the ubiquitination of AnkB. This can be achieved by 
immunoprecipitating AnkB from Trim21 knockout cells and detecting ubiquitination of 
AnkB by Western Blot or more specific mass spectrometry. To determine if Trim21 is a 
substrate of AnkB we can perform co-immunoprecipitation experiments with an AnkB 
variant lacking the ankyrin domains and probe the Western Blot membrane with anti-Trim21. 
These future experiments will help solidify the mechanism AnkB utilizes during intracellular 
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